{"gene":"GDF5","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1997,"finding":"A point mutation in CDMP1/GDF5 substituting the first conserved cysteine in the mature active domain produces a protein that is not secreted and is inactive in vitro; it exerts a dominant-negative effect by preventing secretion of other related BMP family members, proposed to occur through heterodimer formation.","method":"In vitro secretion assay, functional activity assay, dominant-negative analysis in cell culture","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro secretion and activity assays plus dominant-negative functional test in single study; heterodimer mechanism proposed but not fully reconstituted","pmids":["9288098"],"is_preprint":false},{"year":1999,"finding":"GDF5 is necessary and sufficient for cartilage development and restriction of joint formation to appropriate locations in the digits; recombinant GDF5 protein applied to developing chick and mouse limbs promotes cartilage growth and defines joint-forming boundaries, linking cartilage and joint development.","method":"Recombinant protein bead implantation in chick and mouse limb buds; genetic analysis of brachypodism mutants; in vivo loss-of-function and gain-of-function","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal loss-of-function (brachypodism mutants) and gain-of-function (protein bead implantation) experiments replicated across two species","pmids":["10208739"],"is_preprint":false},{"year":1999,"finding":"The BMP antagonist Noggin binds to GDF5 and inhibits all observed effects of GDF5 in vivo (cartilage growth, digit morphogenesis); BMP-7 negatively regulates Gdf5 gene expression in joint-forming regions; Noggin treatment induces ectopic Gdf5 expression in interdigital mesoderm.","method":"In vivo chick bead implantation with Noggin; in situ hybridization; retroviral misexpression of Hedgehog signals","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo binding-consequence experiment and expression regulation demonstrated in single study with multiple approaches","pmids":["9918693"],"is_preprint":false},{"year":2000,"finding":"BMPR1B (ALK6) is the physiological type I receptor transducing GDF5 signal for digit cartilage formation; GDF5 acts through both BMPR1B-dependent and -independent processes; epistasis analysis shows BMPR1B regulates chondrogenesis and segmentation partly through GDF5 and partly independently, and GDF5 can signal through type I receptors other than BMPR1B.","method":"Mouse insertional mutant (BmprIB regulatory allele), double mutant genetic epistasis (Gdf5 x BmprIB), expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with compound mutants in mice, complementary expression analyses","pmids":["10631181"],"is_preprint":false},{"year":2001,"finding":"GDF5 acts at two stages of skeletal development: first it promotes chondrogenic cell condensation by increasing cell adhesion; second, it increases skeletal element size by stimulating cell proliferation in epiphyseal cartilage. Retroviral overexpression of GDF5 in chick limb increased element size and S-phase cells; in vitro micromass cultures showed increased cell adhesiveness.","method":"Retroviral overexpression (RCAS) in chick embryo, autoradiography (S-phase labeling), micromass and single-cell suspension cultures of limb mesenchyme","journal":"The Journal of bone and joint surgery. American volume","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo overexpression plus in vitro functional assays in single study with two orthogonal approaches","pmids":["11263662"],"is_preprint":false},{"year":2003,"finding":"Members of the GDF5/6/7 subgroup are expressed in distinct subsets of developing joints and are required for joint, ligament, and cartilage formation at different skeletal sites; Gdf5 and Gdf6 double mutants show additive/synergistic defects, establishing functional redundancy and distinct spatial roles within the subgroup.","method":"Single and double null mouse mutant analysis, skeletal phenotyping","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous double-knockout epistasis in mice with comprehensive skeletal phenotyping","pmids":["12606286"],"is_preprint":false},{"year":2004,"finding":"Ror2 (tyrosine kinase receptor) and BMPR1B (BRI-b, serine/threonine kinase receptor) form a ligand-independent heteromeric complex; the frizzled-like CRD domain of Ror2 is required for this complex; within the complex Ror2 is transphosphorylated by BMPR1B; Ror2 modulates GDF5 signaling by inhibiting Smad1/5 signaling and activating a Smad-independent pathway, both required for chondrogenic differentiation. Epistatic interactions in Ror2, BMPR1B, and Gdf5 compound mutant mice confirm in vivo functional interaction.","method":"Co-immunoprecipitation, domain-deletion mutants, phosphorylation assays, Smad reporter assays, ATDC5 chondrogenesis assay, compound mutant mouse genetics","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal Co-IP, phosphorylation assay, reporter assay, and in vivo epistasis in compound mutant mice","pmids":["15569154"],"is_preprint":false},{"year":2004,"finding":"GDF5 and BMP4 have distinct functions during chondrogenesis: GDF5 increases the number of prechondrogenic condensations and cartilaginous nodules without altering overall differentiation pattern, and causes sustained elevated Sox9 expression and only transient Col10 upregulation; BMP4 is instructive and induces mesenchymal cells toward the chondrogenic lineage with accelerated maturation.","method":"Mouse embryonic limb bud micromass culture with recombinant protein treatment, gene expression analysis, histology","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic comparative micromass culture with multiple markers in single study","pmids":["15048875"],"is_preprint":false},{"year":2005,"finding":"GDF5 L441P mutation causes brachydactyly type A2 by abolishing binding to both BMPR1A and BMPR1B ectodomains (loss of function); GDF5 R438L mutation causes symphalangism by acquiring increased binding to BMPR1A (normally BMP2's receptor) while retaining normal BMPR1B binding — a gain of BMP2-like receptor-binding specificity; both mutants show normal Noggin binding. This identifies key receptor-binding specificity determinants in GDF5.","method":"Biosensor (SPR) interaction analyses with receptor ectodomains, recombinant protein expression, limb bud micromass culture, ATDC5 and C2C12 cell treatment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative SPR binding assays plus functional cell-based assays for two distinct mutations, multiple orthogonal methods in one rigorous study","pmids":["16127465"],"is_preprint":false},{"year":2006,"finding":"GDF5 binds specifically to BMPR1b, BMPR2, and ACTR2a receptors; GDF5 induces phosphorylation of Smad1/5/8 and their nuclear translocation, upregulating ID1 and ID3 expression via a Smad-dependent, MAPK-independent pathway in human vascular smooth muscle cells; GDF5 also has chemotactic activity partially dependent on Smad1 and ID1.","method":"Receptor expression analysis, Smad phosphorylation assay, Smad1 siRNA knockdown, ID1/ID3 reporter/expression assays, p38/ERK inhibitors, chemotaxis assay in HUVSMC","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown, specific inhibitors, and phosphorylation assays in single study","pmids":["16716349"],"is_preprint":false},{"year":2008,"finding":"GDF5 N445K and N445T mutations found in multiple synostosis syndrome patients confer resistance to the BMP inhibitor Noggin and altered signaling, causing gain of chondrogenic function. Residue N445 is a key determinant of Noggin sensitivity; BMP9 and BMP10, which naturally have lysine at this position, are also insensitive to Noggin. Swapping two additional residues was required to render BMP9 Noggin-sensitive, demonstrating that this residue is part of the antagonist interface.","method":"Patient mutation identification, functional studies in chicken micromass culture, ectopic cartilage induction in chick in vivo, sequence and structural comparison","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo chick model plus in vitro functional assays, site-directed mutagenesis approach, and structural reasoning corroborated across multiple mutants","pmids":["19956691"],"is_preprint":false},{"year":2009,"finding":"GDF5 and BMP2 prevent apoptosis in mouse embryonic fibroblasts (but not smooth muscle cells) via BMPR2; both factors stimulate interaction of BMPR2 with XIAP, reducing XIAP ubiquitination and increasing XIAP protein stability, which then inactivates caspases. This anti-apoptotic mechanism is independent of Smad and MAPK signaling.","method":"Apoptosis assay, Co-IP of BMPR2 with XIAP, ubiquitination assay, caspase activity assay, in isolated MEFs and SMCs","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination, and functional apoptosis assays in single study with multiple orthogonal methods","pmids":["19782107"],"is_preprint":false},{"year":2008,"finding":"GDF5 promotes chondrogenesis downstream of BMPR1B (ALK6)/Alk6 signaling; Trps1 protein levels and nuclear translocation are upregulated by GDF5 treatment in a dose-dependent manner via Alk6 and p38 MAPK signaling; Trps1 acts downstream of GDF5 to promote chondrocyte differentiation and apoptosis, and also suppresses Gdf5 expression in a negative feedback loop.","method":"GDF5 protein treatment of ATDC5 cells, dominant-negative Alk6 (dn-Alk6) inhibition, p38 MAPK inhibitor (SB203580), Trps1 overexpression and knockdown, Western blot, immunofluorescence","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacologic inhibitors plus gain/loss-of-function in single study","pmids":["18363966"],"is_preprint":false},{"year":2009,"finding":"The OA-risk T allele of rs143383 in the GDF5 5'-UTR mediates reduced GDF5 expression in all joint tissues tested (cartilage, synovium, ligament), demonstrating a joint-wide cis-regulatory effect; a second 3'-UTR polymorphism influences allelic expression of GDF5 independent of rs143383; DEAF-1 protein binds differentially to the two alleles of rs143383 (trans-acting factor).","method":"Allelic expression imbalance assay in patient tissue, luciferase reporter assay, electrophoretic mobility shift assay (EMSA)","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — allelic expression in multiple tissue types, EMSA for trans-factor binding, single lab","pmids":["19565498"],"is_preprint":false},{"year":2011,"finding":"DNA methylation of the GDF5 promoter and 5'-UTR regulates GDF5 expression; demethylation correlates with increased GDF5 expression; the CpG sites created by the C alleles of rs143383 and rs143384 are variably methylated; demethylating agent treatment of a heterozygous cell line further increases allelic expression imbalance between C and T alleles, demonstrating epigenetic modulation of the rs143383 genetic effect.","method":"Bisulfite methylation analysis, demethylating agent (5-aza-2'-deoxycytidine) treatment, allelic expression quantification in cell lines and joint tissues","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — methylation analysis plus pharmacological manipulation in cell lines and patient tissue, single lab","pmids":["21642387"],"is_preprint":false},{"year":2013,"finding":"Sp1, Sp3, P15, and DEAF-1 are trans-acting factors that bind to the GDF5 5'-UTR at rs143383; Sp1, Sp3, and DEAF-1 are repressors of GDF5 expression; DEAF-1 preferentially represses the T allele of rs143383 relative to the C allele, contributing to differential allelic expression; Sp1 and DEAF-1 in combination show greatest repressive activity.","method":"Competition and supershift EMSA, oligonucleotide pulldown with quantitative mass spectrometry, chromatin immunoprecipitation (ChIP), RNA interference (siRNA knockdown), overexpression assays","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (EMSA, MS proteomics, ChIP, RNAi, overexpression) all converging on same trans-factor identification in single rigorous study","pmids":["23825960"],"is_preprint":false},{"year":2013,"finding":"SOX11 directly activates GDF5 expression by binding to conserved SOX family binding sites in the GDF5 5'-UTR, as demonstrated by in vitro and micromass culture overexpression; SOX11 misexpression in developing chick limbs via RCAS virus enhances but does not ectopically induce Gdf5 expression.","method":"SOX11 overexpression in vitro and in micromass cultures, RCAS retroviral infection in chick limb, reporter/expression assays, binding site identification","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding site identification, gain-of-function in vitro and in vivo, single lab","pmids":["23356643"],"is_preprint":false},{"year":2013,"finding":"GDF5 stimulation of human chondrocytes inhibits expression of catabolic enzymes MMP13 and ADAMTS4, and upregulates anabolic genes ACAN and SOX9; this is mediated through upregulation of Wnt inhibitors DKK1 and FRZB, and MMP13 inhibition is specifically dependent on DKK1 (blocking canonical Wnt signaling).","method":"Human chondrocyte pellet culture, qPCR, ELISA for protein levels, Wnt3a and CHIR-99021 stimulation, DKK1 inhibitor (WAY-262611) co-treatment","journal":"Osteoarthritis and cartilage","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with multiple growth factor doses and inhibitors in primary human cells, single lab","pmids":["24561281"],"is_preprint":false},{"year":2014,"finding":"CpG methylation at the +37 site (4 bp upstream of rs143383) within the SP1/SP3 binding site has an allele-specific effect: methylation at this site attenuates SP1, SP3, and DEAF-1 repression of GDF5 promoter activity, and modulates the level and direction of allelic imbalance at rs143383. OA knee cartilage shows greater demethylation at +37 compared with hip cartilage, potentially explaining the knee-specific OA association.","method":"Bisulfite sequencing of normal and OA cartilage, methylation-sensitive EMSA for SP1/SP3 binding, luciferase promoter reporter assays with methylated constructs","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and reporter assays with methylated vs unmethylated templates, patient tissue analysis, single lab","pmids":["24861163"],"is_preprint":false},{"year":2012,"finding":"YY1 is a trans-acting activator of GDF5: it differentially binds to the alleles of a -41 bp promoter variant (more avidly to the A allele), and YY1 knockdown significantly reduces GDF5 expression; the A allele at -41 bp compensates for reduced expression mediated by the T allele of rs143383, identifying a regulatory site that can be manipulated to modulate GDF5 expression.","method":"Luciferase reporter assay, EMSA, YY1 siRNA knockdown","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and functional reporter plus siRNA knockdown in single study","pmids":["22929025"],"is_preprint":false},{"year":2013,"finding":"GDF5 and BMP2 induce neurite outgrowth in SH-SY5Y human neuronal cells via a direct neuronal mechanism (not indirect glial effect), dependent on BMP type I receptor activation of canonical Smad1/5/8 signaling.","method":"SH-SY5Y cell culture with GDF5 and BMP2, Smad1/5/8 phosphorylation assay, BMP receptor activation assay","journal":"Molecular and cellular neurosciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, limited mechanistic dissection (pathway inhibition not fully detailed in abstract)","pmids":["23831389"],"is_preprint":false},{"year":2015,"finding":"GDF5 acts as a context-dependent BMP-2 antagonist: in C2C12 cells (but not ATDC5 cells), GDF5 and its BMPR-IA-binding variant GDF5 R57A antagonize BMP2-mediated ALP expression even when signaling occurs solely via BMPR-IA; this context-dependency suggests an additional unidentified GDF5-specific co-receptor modulates signaling output.","method":"ALP assay in ATDC5 and C2C12 cells, in vivo heterotopic implantation in mice, crystal structure comparison of GDF5 R57A:BMPR-IA and BMP2:BMPR-IA complexes","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — crystal structure plus in vitro functional assay plus in vivo heterotopic implant; antagonism mechanism inferred but co-receptor not identified","pmids":["26385096"],"is_preprint":false},{"year":2016,"finding":"The crystal structure of Gremlin-2 (a DAN-family BMP antagonist) bound to GDF5 at 2.9-Å resolution reveals two Grem2 dimers binding perpendicularly to each GDF5 monomer in an H-like structure; upon complex formation, the dynamic N-terminus of Grem2 undergoes significant conformational change to simultaneously interact with both type I and type II receptor motifs on GDF5. DAN-family members can interact with BMP-type I receptor complexes (unlike Noggin which outcompetes the type I receptor), and Grem2-GDF5 forms a stable aggregate-like structure in vitro.","method":"X-ray crystallography (2.9-Å resolution), binding studies (SPR/biochemical), structural comparison with unbound Grem2","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional binding validation; mechanistic conclusions directly from structural data","pmids":["27524626"],"is_preprint":false},{"year":2016,"finding":"Gdf5-positive interzone cells continuously influx into developing joints rather than arising from a single early set of progenitors; using a knockin Gdf5-CreERT2 mouse, early labeling of Gdf5+ cells failed to mark the entire joint, while multiple sequential Cre activation steps showed progressive contribution to various joint compartments; spatiotemporal differences in Gdf5 expression may instruct lineage divergence into different joint tissues.","method":"Gdf5-CreERT2 knockin mouse lineage tracing, inducible Cre activation at multiple time points, tdTomato reporter","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous inducible lineage-tracing with temporal resolution using knockin mouse model","pmids":["27292641"],"is_preprint":false},{"year":2016,"finding":"Separate modular enhancers distributed over >100 kb of the Gdf5 locus (including upstream and downstream regions) control expression in distinct joint subsets (axial vs. limb, proximal vs. distal, specific sub-joints like elbow); predicted transcription factor binding sites within these enhancers are required for expression in particular joints; functional rescue in mice confirmed large flanking regions are required for normal joint formation.","method":"Transgenic mouse enhancer reporter assays, systematic locus survey, functional rescue tests in Gdf5 mutant mice","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic in vivo enhancer mapping with functional rescue in mice, multiple enhancers validated","pmids":["27902701"],"is_preprint":false},{"year":2017,"finding":"A novel growth enhancer (GROW1) downstream of Gdf5 controls expression at the growing ends of long bones (not joints); GROW1 is required for normal Gdf5 expression at bone ends and normal bone lengths in vivo; a common human base-pair change in GROW1 decreases enhancer activity; the derived allele colocalizes with signatures of positive selection in Neandertals, Denisovans, and non-African humans.","method":"Transgenic mouse enhancer assays, GROW1 deletion in vivo, human variant functional reporter assay, population genetics analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo enhancer deletion plus reporter assays plus in vivo bone length phenotype, multiple orthogonal methods","pmids":["28671685"],"is_preprint":false},{"year":2018,"finding":"The embryonic CaVβ1 isoform (CaVβ1E) boosts GDF5 expression downstream of its induction by muscle denervation; CaVβ1E overexpression improves muscle mass wasting in aging mice by increasing GDF5 expression; loss of CaVβ1E in aged muscle is associated with attenuated GDF5-dependent response to denervation.","method":"CaVβ1E overexpression mouse model, sciatic denervation model, CaVβ1E knockout in aging, GDF5 expression measurement","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss- and gain-of-function in mice with defined phenotypic readout; pathway placement via epistasis-like approach","pmids":["31694926"],"is_preprint":false},{"year":2015,"finding":"Gdf5 progenitors in the enthesis give rise to fibrocartilage cells that mineralize via hedgehog signaling; hedgehog (Hh) pathway is required for enthesis mineralization, as tissue-specific deletion of Smoothened (the obligate Hh transducer) in tendon/enthesis cells leads to significant reductions in mineralized fibrocartilage apposition.","method":"Gdf5-Cre lineage tracing, tissue-specific Smoothened conditional knockout, histology, immunohistochemistry","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic lineage tracing plus conditional knockout with defined cellular phenotype","pmids":["26141957"],"is_preprint":false},{"year":2012,"finding":"GDF5 W408R mutation (identified by ENU mutagenesis in mice) is secreted and dimerizes normally but inhibits wild-type GDF5 function in a dominant-negative fashion, causing brachypodism, ankylosis and early-onset osteoarthritis; the mutation resides in a highly conserved region of the active signaling domain.","method":"ENU mutagenesis screen, heterozygous/homozygous phenotypic analysis, dominant-negative functional assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model with dominant-negative functional validation, single lab","pmids":["17656374"],"is_preprint":false},{"year":2012,"finding":"GDF5 S94N mutation (in the knuckle epitope/BMPRII interaction site) impairs binding to BMPRII, reducing Smad and non-Smad signaling and reducing chondrogenic differentiation of ATDC5 cells; paradoxically, the mutation strongly enhances chondrogenesis in mouse micromass cultures because of strongly reduced affinity for Noggin, resulting in gain of function by escaping Noggin inhibition.","method":"SPR quantitative binding assays, reporter gene assay, ALP assay, qPCR, ATDC5 cell differentiation assay, mouse micromass culture","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative SPR binding, reporter assays, and functional differentiation assays with multiple orthogonal methods in single rigorous study","pmids":["21976273"],"is_preprint":false},{"year":2013,"finding":"GDF5 W414R mutation simultaneously causes gain and loss of function: insensitivity to Noggin (gain of function, causing SYNS2) and reduced signaling specifically via BMPR1A (loss of function, causing BDA1). SPR analysis confirmed altered receptor and antagonist binding affinities for this single mutation.","method":"Primary mesenchymal cell chondrogenesis assay, luciferase reporter assay, Surface Plasmon Resonance (SPR) binding analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — SPR quantitative binding plus reporter assays plus functional chondrogenesis assay in single rigorous study demonstrating dual mechanism","pmids":["24098149"],"is_preprint":false},{"year":2018,"finding":"BMP14/GDF5 induces tenogenic differentiation of bone marrow mesenchymal stem cells by upregulating scleraxis, tenomodulin, and Sirt1; BMP14 triggers JNK and Smad1 phosphorylation; Sirt1 deacetylates PPARγ to promote tenogenic differentiation; Sirt1 gain/loss-of-function promotes/inhibits tenogenic differentiation; JNK and Smad1 inhibition increased PPARγ acetylation and inhibited tenogenic markers, defining the BMP14-Sirt1-JNK/Smad1-PPARγ tenogenic differentiation pathway.","method":"BMSCs treated with BMP14, Sirt1 overexpression and knockdown, JNK and Smad inhibitors, acetylation assay, qPCR and Western blot","journal":"Experimental and therapeutic medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss-of-function plus pathway inhibition with multiple readouts in single study","pmids":["30116367"],"is_preprint":false},{"year":2020,"finding":"Gdf5 expression is upregulated in articular cartilage following experimental OA (destabilization of medial meniscus) and after acute cartilage injury; expression in injured synovium inversely correlates with YAP (Yes-associated protein) expression; overexpression of YAP suppresses Gdf5 expression in chondroprogenitors in vitro; Gdf5 upregulation in both injury models requires regulatory sequence downstream of Gdf5 coding exons.","method":"Gdf5-LacZ reporter mouse, DMM experimental OA model, acute cartilage injury model, immunohistochemistry, YAP overexpression in vitro, microarray analysis of human OA cartilage","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo reporter mice plus in vitro YAP overexpression plus required regulatory sequence identified; single lab","pmids":["31932746"],"is_preprint":false},{"year":2003,"finding":"GDF5 intervertebral disc cells express BMPR1A, BMPR1B, and BMPR2 receptors relevant for GDF5 action; adenoviral GDF5 gene transfer produces two secreted forms consistent with activated GDF5 dimer and proform; overexpressed GDF5 is bioactive and promotes growth of rabbit disc cells.","method":"Adenoviral gene transfer, western blot (two GDF5 forms), ELISA, [3H]thymidine proliferation assay, receptor expression analysis","journal":"Journal of molecular medicine (Berlin, Germany)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — receptor identification and growth assay but limited mechanistic depth, single lab","pmids":["14669002"],"is_preprint":false},{"year":2015,"finding":"TGF-β1 and GDF5 synergistically drive differentiation of human adipose stromal cells toward nucleus pulposus-like cells; the Smad2/3 pathway mainly governs acquisition of NP cell molecular identity while the Smad1/5/8 pathway controls NP cell morphology.","method":"hASC culture with growth factors, gene expression analysis, extracellular matrix assessment, in vivo transplantation in nude mice, Smad pathway analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pathway attribution based on expression/signaling analysis without specific inhibitors fully detailed in abstract","pmids":["26661057"],"is_preprint":false}],"current_model":"GDF5 (also known as CDMP1/BMP14) is a secreted BMP-family ligand that preferentially binds the type I receptor BMPR1B (with secondary signaling through BMPR1A and BMPR2) to activate canonical Smad1/5/8 signaling, and is antagonized by Noggin (which blocks both type I and type II receptor-binding epitopes) and DAN-family antagonists like Gremlin-2 (which bind receptor interfaces via a distinct H-shaped structure); it drives joint formation, chondrogenesis, and skeletal patterning through modular tissue-specific enhancers and is modulated at the transcriptional level by methylation of CpG sites in its 5'-UTR and by trans-acting repressors (Sp1, Sp3, DEAF-1) and activators (YY1, SOX11); disease-causing mutations alter receptor-binding specificity (gain of BMPR1A binding causing symphalangism) or Noggin-binding resistance (causing multiple synostosis syndrome), while loss-of-function mutations cause brachydactylies and acromesomelic dysplasias; beyond the skeleton, GDF5 promotes tenogenic differentiation via a Sirt1-JNK/Smad1-PPARγ pathway, supports dopaminergic neuron survival via Smad signaling, and inhibits cartilage catabolism by inducing DKK1-mediated Wnt pathway suppression."},"narrative":{"mechanistic_narrative":"GDF5 (CDMP1/BMP14) is a secreted BMP-family ligand that is necessary and sufficient for cartilage growth and for restricting joint formation to its correct positions in the developing skeleton [PMID:10208739]. It acts at sequential stages of skeletal development, first promoting chondrogenic cell condensation through increased cell adhesion and then driving epiphyseal cell proliferation to set skeletal element size [PMID:11263662], and it lineage-marks the continuously recruited interzone cells that build joint compartments and entheseal fibrocartilage [PMID:27292641, PMID:26141957]. GDF5 signals principally through the type I receptor BMPR1B (ALK6) to activate canonical Smad1/5/8 phosphorylation and downstream targets such as ID1/ID3 and Trps1, while also engaging BMPR1A, BMPR2 and Smad-independent (p38, non-Smad) routes [PMID:10631181, PMID:16716349, PMID:18363966]; its output is further shaped by a ligand-independent BMPR1B–Ror2 heteromeric complex that tunes chondrogenic differentiation [PMID:15569154]. Ligand activity is held in check by the antagonist Noggin, which blocks GDF5 effects in vivo [PMID:9918693], and by DAN-family antagonist Gremlin-2, whose crystal structure with GDF5 reveals an H-shaped assembly that occludes both type I and type II receptor motifs [PMID:27524626]. Disease-causing mutations partition cleanly by mechanism: substitutions that abolish or remodel receptor-binding specificity cause brachydactyly and symphalangism (e.g. L441P loss of BMPR1A/B binding; R438L gain of BMPR1A binding) [PMID:16127465], residues at the Noggin interface (N445, W414, S94) confer antagonist resistance producing synostosis or gain-of-function chondrogenesis [PMID:19956691, PMID:21976273, PMID:24098149], and dominant-negative alleles that disrupt secretion or signaling cause brachydactyly, ankylosis and early osteoarthritis [PMID:9288098, PMID:17656374]. GDF5 expression is governed by a >100 kb array of modular tissue-specific enhancers, including the GROW1 long-bone enhancer carrying a positively selected human variant [PMID:27902701, PMID:28671685], and is fine-tuned at the 5'-UTR by CpG methylation and by trans-acting repressors (Sp1, Sp3, DEAF-1) and activators (YY1, SOX11), with the osteoarthritis-risk rs143383 T allele lowering joint-wide GDF5 expression [PMID:19565498, PMID:23825960, PMID:22929025, PMID:23356643, PMID:24861163]. Beyond the skeleton, GDF5 suppresses cartilage catabolism by inducing DKK1-mediated inhibition of canonical Wnt signaling [PMID:24561281], drives tenogenic differentiation via a Sirt1-JNK/Smad1-PPARγ axis [PMID:30116367], and stabilizes XIAP through BMPR2 to confer Smad-independent anti-apoptotic protection [PMID:19782107].","teleology":[{"year":1997,"claim":"Established that GDF5 must be secreted as an active dimer to function and that a cysteine-disrupting mutation acts dominant-negatively, hinting that GDF5 can heterodimerize with related BMP ligands.","evidence":"In vitro secretion and activity assays with dominant-negative analysis in cell culture","pmids":["9288098"],"confidence":"Medium","gaps":["Heterodimer formation proposed but not biochemically reconstituted","Receptor engagement not addressed"]},{"year":1999,"claim":"Defined GDF5 as both necessary and sufficient for cartilage growth and for positioning joints, placing it at the center of skeletal patterning.","evidence":"Recombinant protein bead implantation in chick/mouse limbs plus brachypodism mutant genetics","pmids":["10208739"],"confidence":"High","gaps":["Receptor and intracellular signaling not yet defined","Did not separate proliferative from condensation effects"]},{"year":1999,"claim":"Showed GDF5 activity is extracellularly antagonized by Noggin and that GDF5 expression is itself patterned by BMP7 and Hedgehog inputs.","evidence":"In vivo chick Noggin bead implantation, in situ hybridization, retroviral misexpression","pmids":["9918693"],"confidence":"Medium","gaps":["Noggin binding interface on GDF5 not mapped","Direct vs indirect BMP7 regulation unresolved"]},{"year":2000,"claim":"Identified BMPR1B (ALK6) as the physiological type I receptor for GDF5 in digit chondrogenesis while revealing BMPR1B-independent GDF5 actions.","evidence":"Gdf5 x BmprIB compound mutant genetic epistasis in mice","pmids":["10631181"],"confidence":"High","gaps":["Identity of alternative type I receptors not pinned down","Downstream Smad effectors not directly traced"]},{"year":2001,"claim":"Resolved GDF5 into two temporally distinct skeletal functions: increasing cell adhesion during condensation and stimulating epiphyseal proliferation to set element size.","evidence":"RCAS overexpression in chick, S-phase autoradiography, micromass adhesion assays","pmids":["11263662"],"confidence":"Medium","gaps":["Molecular basis of adhesion increase unknown","Receptor coupling to each stage not dissected"]},{"year":2003,"claim":"Distinguished GDF5 from BMP4 functionally, showing GDF5 expands prechondrogenic condensations and sustains Sox9 without driving lineage instruction or full maturation.","evidence":"Comparative limb bud micromass culture with recombinant proteins and marker analysis","pmids":["15048875"],"confidence":"Medium","gaps":["Receptor-level basis of the functional divergence unclear","Single culture system"]},{"year":2004,"claim":"Revealed that a ligand-independent BMPR1B–Ror2 heteromeric complex modulates GDF5 signaling, balancing Smad inhibition against a Smad-independent pathway during chondrogenesis.","evidence":"Reciprocal Co-IP, domain deletions, phosphorylation/reporter assays, ATDC5, compound mutant mice","pmids":["15569154"],"confidence":"High","gaps":["Identity of the Smad-independent effector not defined","Stoichiometry of the complex unknown"]},{"year":2003,"claim":"Provided early evidence that GDF5 receptors are present on intervertebral disc cells and that recombinant GDF5 dimer is bioactive on disc tissue.","evidence":"Adenoviral GDF5 gene transfer, Western blot, proliferation assay in rabbit disc cells","pmids":["14669002"],"confidence":"Low","gaps":["Limited mechanistic depth and single lab","Signaling pathway not dissected"]},{"year":2005,"claim":"Mapped receptor-binding specificity determinants by showing brachydactyly and symphalangism mutations selectively abolish or acquire type I receptor binding while sparing Noggin binding.","evidence":"SPR binding to receptor ectodomains plus micromass and cell-based functional assays","pmids":["16127465"],"confidence":"High","gaps":["Structural basis of specificity switch not crystallographically resolved here","In vivo recapitulation of human phenotypes limited"]},{"year":2006,"claim":"Confirmed GDF5 activates canonical Smad1/5/8 signaling through BMPR1b/BMPR2/ACTR2a inducing ID1/ID3 in a Smad-dependent, MAPK-independent manner, and added a chemotactic function.","evidence":"Receptor expression analysis, Smad1 siRNA, ID reporters, MAPK inhibitors, chemotaxis in HUVSMC","pmids":["16716349"],"confidence":"Medium","gaps":["Vascular smooth muscle context only","Chemotaxis mechanism partially defined"]},{"year":2007,"claim":"Showed a secretion-competent, normally dimerizing GDF5 mutation (W408R) acts dominant-negatively in vivo, causing brachypodism, ankylosis and early osteoarthritis.","evidence":"ENU mutagenesis mouse model with dominant-negative functional validation","pmids":["17656374"],"confidence":"Medium","gaps":["Molecular interference mechanism not biochemically defined","Single lab"]},{"year":2008,"claim":"Placed Trps1 downstream of GDF5/ALK6–p38 signaling as a driver of chondrocyte differentiation and as a negative feedback repressor of Gdf5.","evidence":"GDF5 treatment of ATDC5, dn-Alk6, p38 inhibitor, Trps1 gain/loss-of-function","pmids":["18363966"],"confidence":"Medium","gaps":["In vivo relevance of Trps1 feedback not tested","Single cell line"]},{"year":2009,"claim":"Defined a Smad/MAPK-independent anti-apoptotic mechanism in which GDF5 promotes BMPR2–XIAP interaction, stabilizing XIAP to inactivate caspases.","evidence":"Apoptosis, Co-IP, ubiquitination and caspase assays in MEFs vs SMCs","pmids":["19782107"],"confidence":"Medium","gaps":["Cell-type specificity unexplained","Physiological context beyond cultured fibroblasts unclear"]},{"year":2009,"claim":"Demonstrated the osteoarthritis-risk rs143383 T allele lowers GDF5 expression joint-wide and that DEAF-1 binds the variant differentially, establishing a cis/trans regulatory disease axis.","evidence":"Allelic expression imbalance in patient tissue, luciferase reporters, EMSA","pmids":["19565498"],"confidence":"Medium","gaps":["Full trans-factor repertoire not yet defined","Causal chain to cartilage degeneration not proven"]},{"year":2008,"claim":"Identified N445 as a Noggin-sensitivity determinant, showing synostosis mutations confer Noggin resistance and gain of chondrogenic function.","evidence":"Patient mutations, chick micromass and in vivo cartilage induction, structural sequence comparison","pmids":["19956691"],"confidence":"High","gaps":["Crystallographic definition of the antagonist interface awaited","Additional residues only inferred from BMP9 swaps"]},{"year":2011,"claim":"Showed DNA methylation of the GDF5 5'-UTR modulates expression and that allele-created CpG sites couple epigenetic state to the rs143383 genetic effect.","evidence":"Bisulfite analysis, demethylating agent treatment, allelic expression quantification","pmids":["21642387"],"confidence":"Medium","gaps":["Enzymes setting methylation marks not identified","Causal directionality in OA tissue unproven"]},{"year":2012,"claim":"Showed a single S94N mutation causing reduced BMPR2 binding paradoxically enhances chondrogenesis by escaping Noggin, illustrating coupled receptor and antagonist interfaces.","evidence":"SPR binding, reporter, ALP, qPCR, ATDC5 and mouse micromass assays","pmids":["21976273"],"confidence":"High","gaps":["In vivo phenotype of S94N not established","Context-dependence across cell types only partly explored"]},{"year":2012,"claim":"Identified YY1 as a trans-activator binding a -41 bp promoter variant that can compensate for the OA-risk rs143383 T allele.","evidence":"Luciferase reporter, EMSA, YY1 siRNA knockdown","pmids":["22929025"],"confidence":"Medium","gaps":["In vivo contribution of YY1 to joint GDF5 not shown","Interaction with repressors not modeled"]},{"year":2013,"claim":"Resolved the trans-acting regulatory network at rs143383, identifying Sp1/Sp3/DEAF-1 as repressors with allele-selective DEAF-1 activity contributing to differential expression.","evidence":"EMSA, oligo pulldown mass spectrometry, ChIP, RNAi, overexpression","pmids":["23825960"],"confidence":"High","gaps":["Combinatorial logic with activators not fully integrated","Tissue specificity of factor occupancy not mapped"]},{"year":2013,"claim":"Identified SOX11 as a direct activator of GDF5 via conserved 5'-UTR SOX sites, enhancing but not ectopically inducing expression.","evidence":"SOX11 overexpression in vitro and in chick micromass/limb, binding site analysis","pmids":["23356643"],"confidence":"Medium","gaps":["Requirement of SOX11 for endogenous Gdf5 not demonstrated by loss-of-function","Single lab"]},{"year":2013,"claim":"Defined a chondroprotective output: GDF5 suppresses catabolic MMP13/ADAMTS4 and raises anabolic ACAN/SOX9 via DKK1/FRZB-mediated inhibition of canonical Wnt signaling.","evidence":"Human chondrocyte pellet culture, qPCR/ELISA, Wnt agonists and DKK1 inhibitor","pmids":["24561281"],"confidence":"Medium","gaps":["In vivo validation of the GDF5-DKK1-Wnt axis lacking","Receptor route to DKK1 induction not traced"]},{"year":2013,"claim":"Provided initial evidence that GDF5 induces neurite outgrowth in human neuronal cells through direct BMP type I receptor–Smad1/5/8 signaling.","evidence":"SH-SY5Y culture, Smad1/5/8 phosphorylation and receptor activation assays","pmids":["23831389"],"confidence":"Low","gaps":["Pathway dissection limited and not confirmed by inhibitors in detail","Single cell line, single lab"]},{"year":2013,"claim":"Showed a single W414R mutation produces simultaneous gain (Noggin insensitivity, SYNS2) and loss (reduced BMPR1A signaling, BDA1) of function, unifying two disease mechanisms in one residue.","evidence":"Mesenchymal chondrogenesis assay, luciferase reporter, SPR binding","pmids":["24098149"],"confidence":"High","gaps":["Structural basis of dual effect not crystallized here","In vivo dual phenotype recapitulation not shown"]},{"year":2014,"claim":"Linked epigenetics to allelic regulation by showing methylation at the +37 SP1/SP3 site attenuates repression and that joint-specific demethylation may underlie knee-selective OA association.","evidence":"Bisulfite sequencing of OA cartilage, methylation-sensitive EMSA, methylated reporter assays","pmids":["24861163"],"confidence":"Medium","gaps":["Mechanism of joint-specific demethylation unknown","Causality vs correlation in OA not resolved"]},{"year":2015,"claim":"Showed GDF5+ enthesis progenitors give rise to fibrocartilage that mineralizes through Hedgehog signaling, extending GDF5 lineage roles to tendon-bone attachment.","evidence":"Gdf5-Cre lineage tracing with Smoothened conditional knockout","pmids":["26141957"],"confidence":"High","gaps":["Role of GDF5 ligand itself (vs lineage marker) in enthesis not isolated","Hh-GDF5 crosstalk not defined"]},{"year":2015,"claim":"Demonstrated GDF5 can act as a context-dependent BMP2 antagonist even through BMPR-IA, implying an unidentified GDF5-specific co-receptor shapes signaling output.","evidence":"ALP assays in ATDC5/C2C12, heterotopic implantation, crystal structures of GDF5 R57A:BMPR-IA","pmids":["26385096"],"confidence":"Medium","gaps":["The proposed co-receptor was not identified","Antagonism mechanism inferred rather than reconstituted"]},{"year":2015,"claim":"Showed GDF5 synergizes with TGF-β1 to differentiate human adipose stromal cells toward nucleus pulposus cells, with Smad2/3 controlling identity and Smad1/5/8 controlling morphology.","evidence":"hASC culture, gene/ECM analysis, in vivo transplant, Smad pathway analysis","pmids":["26661057"],"confidence":"Low","gaps":["Pathway attribution lacked specific inhibitor confirmation","Single lab"]},{"year":2016,"claim":"Provided lineage-tracing evidence that joints are built by continuous influx of Gdf5+ interzone cells rather than a fixed early progenitor pool.","evidence":"Gdf5-CreERT2 knockin inducible lineage tracing at multiple timepoints","pmids":["27292641"],"confidence":"High","gaps":["Signals directing lineage divergence into joint tissues unknown","Molecular heterogeneity of influxing cells uncharacterized"]},{"year":2016,"claim":"Determined the Gremlin-2:GDF5 crystal structure, showing an H-shaped assembly in which DAN-family antagonists occlude both type I and type II receptor motifs, distinct from Noggin's mode.","evidence":"X-ray crystallography at 2.9 Å with binding validation","pmids":["27524626"],"confidence":"High","gaps":["Functional consequence of Grem2-GDF5 aggregates in vivo unknown","Selectivity of DAN family for GDF5 vs other BMPs not fully mapped"]},{"year":2016,"claim":"Mapped a >100 kb array of modular enhancers controlling Gdf5 expression in distinct joint subsets, explaining its spatially precise skeletal deployment.","evidence":"Transgenic enhancer reporters and functional rescue in Gdf5 mutant mice","pmids":["27902701"],"confidence":"High","gaps":["Specific transcription factors at each enhancer only predicted","Enhancer-promoter looping architecture not defined"]},{"year":2017,"claim":"Identified the GROW1 long-bone enhancer regulating Gdf5 at growing bone ends, with a positively selected human variant that lowers enhancer activity, linking GDF5 regulation to human skeletal evolution.","evidence":"Transgenic enhancer assays, in vivo GROW1 deletion, human variant reporters, population genetics","pmids":["28671685"],"confidence":"High","gaps":["Molecular consequence of the variant on bone length in humans not directly measured","Trans-factors at GROW1 unidentified"]},{"year":2018,"claim":"Defined a BMP14/GDF5-Sirt1-JNK/Smad1-PPARγ pathway driving tenogenic differentiation of mesenchymal stem cells.","evidence":"BMSC treatment, Sirt1 gain/loss, JNK/Smad inhibitors, acetylation assays","pmids":["30116367"],"confidence":"Medium","gaps":["In vivo tendon repair relevance not established","Receptor route to JNK/Smad1 activation not defined"]},{"year":2019,"claim":"Placed GDF5 downstream of an embryonic CaVβ1 isoform in denervated muscle, linking GDF5 induction to muscle mass maintenance during aging.","evidence":"CaVβ1E gain/loss-of-function mouse models, denervation, GDF5 expression measurement","pmids":["31694926"],"confidence":"Medium","gaps":["Direct GDF5 signaling effectors in muscle not defined","Causal sufficiency of GDF5 for muscle phenotype not isolated"]},{"year":2020,"claim":"Showed Gdf5 is upregulated in articular cartilage after osteoarthritis and injury through a downstream regulatory sequence and is repressed by YAP, tying GDF5 to injury-responsive repair signaling.","evidence":"Gdf5-LacZ reporter mice, DMM and acute injury models, YAP overexpression, human OA microarray","pmids":["31932746"],"confidence":"Medium","gaps":["Mechanism coupling YAP to the regulatory sequence unknown","Functional benefit of injury-induced GDF5 not tested"]},{"year":null,"claim":"The identity of the GDF5-specific co-receptor inferred from context-dependent BMP2 antagonism, and the unifying structural rules linking receptor-binding and Noggin-binding interfaces across GDF5 disease mutations, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No co-receptor molecularly identified","No single structural framework reconciles overlapping receptor/antagonist interfaces","Causal in vivo link from cis-regulatory variants to osteoarthritis progression unproven"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,8,9,29,30]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,6,9,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,21,22]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,33]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,5,23,24,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,9,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,10,28,30]}],"complexes":[],"partners":["BMPR1B","BMPR1A","BMPR2","NOG","GREM2","ROR2","XIAP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P43026","full_name":"Growth/differentiation factor 5","aliases":["Bone morphogenetic protein 14","BMP-14","Cartilage-derived morphogenetic protein 1","CDMP-1","Lipopolysaccharide-associated protein 4","LAP-4","LPS-associated protein 4","Radotermin"],"length_aa":501,"mass_kda":55.4,"function":"Growth factor involved in bone and cartilage formation. During cartilage development regulates differentiation of chondrogenic tissue through two pathways. Firstly, positively regulates differentiation of chondrogenic tissue through its binding of high affinity with BMPR1B and of less affinity with BMPR1A, leading to induction of SMAD1-SMAD5-SMAD8 complex phosphorylation and then SMAD protein signaling transduction (PubMed:15530414, PubMed:21976273, PubMed:24098149, PubMed:25092592). Secondly, negatively regulates chondrogenic differentiation through its interaction with NOG (PubMed:21976273). Required to prevent excessive muscle loss upon denervation. This function requires SMAD4 and is mediated by phosphorylated SMAD1/5/8 (By similarity). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205)","subcellular_location":"Secreted; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P43026/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GDF5","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GDF5","total_profiled":1310},"omim":[{"mim_id":"616849","title":"BRACHYDACTYLY, TYPE A1, D; BDA1D","url":"https://www.omim.org/entry/616849"},{"mim_id":"616145","title":"CATEL-MANZKE SYNDROME; CATMANS","url":"https://www.omim.org/entry/616145"},{"mim_id":"615866","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM; IDDMOH","url":"https://www.omim.org/entry/615866"},{"mim_id":"615298","title":"SYMPHALANGISM, PROXIMAL, 1B; SYM1B","url":"https://www.omim.org/entry/615298"},{"mim_id":"615072","title":"BRACHYDACTYLY, TYPE A1, C; BDA1C","url":"https://www.omim.org/entry/615072"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"salivary gland","ntpm":9.3}],"url":"https://www.proteinatlas.org/search/GDF5"},"hgnc":{"alias_symbol":["CDMP1","BMP14"],"prev_symbol":[]},"alphafold":{"accession":"P43026","domains":[{"cath_id":"2.60.120.970","chopping":"200-247_261-347","consensus_level":"medium","plddt":86.9316,"start":200,"end":347},{"cath_id":"2.10.90.10","chopping":"355-378_397-501","consensus_level":"high","plddt":88.176,"start":355,"end":501}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43026","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43026-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43026-F1-predicted_aligned_error_v6.png","plddt_mean":70.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GDF5","jax_strain_url":"https://www.jax.org/strain/search?query=GDF5"},"sequence":{"accession":"P43026","fasta_url":"https://rest.uniprot.org/uniprotkb/P43026.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43026/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43026"}},"corpus_meta":[{"pmid":"18193045","id":"PMC_18193045","title":"Common variants in the GDF5-UQCC region are associated with variation in human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18193045","citation_count":315,"is_preprint":false},{"pmid":"10208739","id":"PMC_10208739","title":"GDF5 coordinates bone and joint formation during digit development.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10208739","citation_count":309,"is_preprint":false},{"pmid":"12606286","id":"PMC_12606286","title":"Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12606286","citation_count":272,"is_preprint":false},{"pmid":"9288098","id":"PMC_9288098","title":"Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.","date":"1997","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9288098","citation_count":271,"is_preprint":false},{"pmid":"30170617","id":"PMC_30170617","title":"Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30170617","citation_count":207,"is_preprint":false},{"pmid":"10404008","id":"PMC_10404008","title":"Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis.","date":"1999","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/10404008","citation_count":201,"is_preprint":false},{"pmid":"10631181","id":"PMC_10631181","title":"Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10631181","citation_count":176,"is_preprint":false},{"pmid":"16127465","id":"PMC_16127465","title":"Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16127465","citation_count":170,"is_preprint":false},{"pmid":"17616513","id":"PMC_17616513","title":"An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17616513","citation_count":168,"is_preprint":false},{"pmid":"9918693","id":"PMC_9918693","title":"Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9918693","citation_count":165,"is_preprint":false},{"pmid":"19479880","id":"PMC_19479880","title":"Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19479880","citation_count":152,"is_preprint":false},{"pmid":"11263662","id":"PMC_11263662","title":"Growth/differentiation factor-5 (GDF-5) and skeletal development.","date":"2001","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/11263662","citation_count":126,"is_preprint":false},{"pmid":"27292641","id":"PMC_27292641","title":"Joint Development Involves a Continuous Influx of Gdf5-Positive Cells.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27292641","citation_count":119,"is_preprint":false},{"pmid":"15048875","id":"PMC_15048875","title":"Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15048875","citation_count":116,"is_preprint":false},{"pmid":"21436509","id":"PMC_21436509","title":"Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems.","date":"2011","source":"Biomedical materials (Bristol, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21436509","citation_count":114,"is_preprint":false},{"pmid":"21642387","id":"PMC_21642387","title":"Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21642387","citation_count":96,"is_preprint":false},{"pmid":"17545436","id":"PMC_17545436","title":"BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury.","date":"2007","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/17545436","citation_count":95,"is_preprint":false},{"pmid":"19565498","id":"PMC_19565498","title":"Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19565498","citation_count":92,"is_preprint":false},{"pmid":"26141957","id":"PMC_26141957","title":"Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26141957","citation_count":91,"is_preprint":false},{"pmid":"24861163","id":"PMC_24861163","title":"CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24861163","citation_count":86,"is_preprint":false},{"pmid":"15569154","id":"PMC_15569154","title":"Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15569154","citation_count":80,"is_preprint":false},{"pmid":"16532400","id":"PMC_16532400","title":"GDF5 is a second locus for multiple-synostosis syndrome.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16532400","citation_count":80,"is_preprint":false},{"pmid":"15187242","id":"PMC_15187242","title":"Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow.","date":"2004","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15187242","citation_count":79,"is_preprint":false},{"pmid":"21360499","id":"PMC_21360499","title":"GDF5 single-nucleotide polymorphism rs143383 is associated with lumbar disc degeneration in Northern European women.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21360499","citation_count":79,"is_preprint":false},{"pmid":"28671685","id":"PMC_28671685","title":"Ancient selection for derived alleles at a GDF5 enhancer influencing human growth and osteoarthritis risk.","date":"2017","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28671685","citation_count":79,"is_preprint":false},{"pmid":"24561281","id":"PMC_24561281","title":"GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition.","date":"2014","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/24561281","citation_count":78,"is_preprint":false},{"pmid":"29550439","id":"PMC_29550439","title":"Heparin functionalization increases retention of TGF-β2 and GDF5 on biphasic silk fibroin scaffolds for tendon/ligament-to-bone tissue engineering.","date":"2018","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/29550439","citation_count":77,"is_preprint":false},{"pmid":"19956691","id":"PMC_19956691","title":"Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19956691","citation_count":76,"is_preprint":false},{"pmid":"31660079","id":"PMC_31660079","title":"3D-bioprinting a genetically inspired cartilage scaffold with GDF5-conjugated BMSC-laden hydrogel and polymer for cartilage repair.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31660079","citation_count":72,"is_preprint":false},{"pmid":"26661057","id":"PMC_26661057","title":"TGF-β1 and GDF5 Act Synergistically to Drive the Differentiation of Human Adipose Stromal Cells toward Nucleus Pulposus-like Cells.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26661057","citation_count":68,"is_preprint":false},{"pmid":"18180771","id":"PMC_18180771","title":"Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.","date":"2008","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18180771","citation_count":66,"is_preprint":false},{"pmid":"12121354","id":"PMC_12121354","title":"Mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome).","date":"2002","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12121354","citation_count":65,"is_preprint":false},{"pmid":"19054821","id":"PMC_19054821","title":"Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19054821","citation_count":64,"is_preprint":false},{"pmid":"31932746","id":"PMC_31932746","title":"Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31932746","citation_count":62,"is_preprint":false},{"pmid":"27902701","id":"PMC_27902701","title":"Heads, Shoulders, Elbows, Knees, and Toes: Modular Gdf5 Enhancers Control Different Joints in the Vertebrate Skeleton.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27902701","citation_count":60,"is_preprint":false},{"pmid":"20633687","id":"PMC_20633687","title":"Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population.","date":"2010","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/20633687","citation_count":59,"is_preprint":false},{"pmid":"17656374","id":"PMC_17656374","title":"A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17656374","citation_count":55,"is_preprint":false},{"pmid":"24291420","id":"PMC_24291420","title":"Photo-cured hyaluronic acid-based hydrogels containing growth and differentiation factor 5 (GDF-5) for bone tissue regeneration.","date":"2013","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24291420","citation_count":55,"is_preprint":false},{"pmid":"24388383","id":"PMC_24388383","title":"The effect of a bioactive collagen membrane releasing PDGF or GDF-5 on bone regeneration.","date":"2013","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/24388383","citation_count":53,"is_preprint":false},{"pmid":"14735582","id":"PMC_14735582","title":"Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14735582","citation_count":52,"is_preprint":false},{"pmid":"23825960","id":"PMC_23825960","title":"The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23825960","citation_count":51,"is_preprint":false},{"pmid":"14669002","id":"PMC_14669002","title":"Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells.","date":"2003","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/14669002","citation_count":51,"is_preprint":false},{"pmid":"12567410","id":"PMC_12567410","title":"Broad phenotypic spectrum caused by an identical heterozygous CDMP-1 mutation in three unrelated families.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12567410","citation_count":50,"is_preprint":false},{"pmid":"23831389","id":"PMC_23831389","title":"BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons.","date":"2013","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/23831389","citation_count":47,"is_preprint":false},{"pmid":"12124730","id":"PMC_12124730","title":"Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12124730","citation_count":46,"is_preprint":false},{"pmid":"30660009","id":"PMC_30660009","title":"Sustained release of GDF5 from a designed coacervate attenuates disc degeneration in a rat model.","date":"2019","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/30660009","citation_count":45,"is_preprint":false},{"pmid":"18283415","id":"PMC_18283415","title":"Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism.","date":"2008","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18283415","citation_count":45,"is_preprint":false},{"pmid":"27524626","id":"PMC_27524626","title":"Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27524626","citation_count":42,"is_preprint":false},{"pmid":"23356643","id":"PMC_23356643","title":"SOX11 contributes to the regulation of GDF5 in joint maintenance.","date":"2013","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23356643","citation_count":39,"is_preprint":false},{"pmid":"18363966","id":"PMC_18363966","title":"Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.","date":"2008","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/18363966","citation_count":39,"is_preprint":false},{"pmid":"26385096","id":"PMC_26385096","title":"GDF-5 can act as a context-dependent BMP-2 antagonist.","date":"2015","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/26385096","citation_count":37,"is_preprint":false},{"pmid":"22284607","id":"PMC_22284607","title":"Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis.","date":"2012","source":"Joint bone spine","url":"https://pubmed.ncbi.nlm.nih.gov/22284607","citation_count":36,"is_preprint":false},{"pmid":"16425226","id":"PMC_16425226","title":"Differential regulation of GDF-5 and FGF-2/4 by immobilisation in ovo exposes distinct roles in joint formation.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16425226","citation_count":36,"is_preprint":false},{"pmid":"22929025","id":"PMC_22929025","title":"A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipulated to modulate GDF5 expression.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22929025","citation_count":35,"is_preprint":false},{"pmid":"19782107","id":"PMC_19782107","title":"GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19782107","citation_count":34,"is_preprint":false},{"pmid":"16716349","id":"PMC_16716349","title":"Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.","date":"2006","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/16716349","citation_count":34,"is_preprint":false},{"pmid":"36901991","id":"PMC_36901991","title":"Skeletal Muscle-Derived Exosomal miR-146a-5p Inhibits Adipogenesis by Mediating Muscle-Fat Axis and Targeting GDF5-PPARγ Signaling.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36901991","citation_count":34,"is_preprint":false},{"pmid":"32508644","id":"PMC_32508644","title":"Long Noncoding RNA GAS5 Promotes Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Regulating GDF5 and p38/JNK Signaling Pathway.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32508644","citation_count":34,"is_preprint":false},{"pmid":"35563063","id":"PMC_35563063","title":"Regulatory Mechanisms of Prg4 and Gdf5 Expression in Articular Cartilage and Functions in Osteoarthritis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35563063","citation_count":33,"is_preprint":false},{"pmid":"24098149","id":"PMC_24098149","title":"A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24098149","citation_count":33,"is_preprint":false},{"pmid":"26010756","id":"PMC_26010756","title":"Regulation of α5 and αV Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26010756","citation_count":33,"is_preprint":false},{"pmid":"16185246","id":"PMC_16185246","title":"The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.","date":"2005","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/16185246","citation_count":32,"is_preprint":false},{"pmid":"27385596","id":"PMC_27385596","title":"Inhibition of microRNA-34a prevents IL-1β-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression.","date":"2016","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/27385596","citation_count":32,"is_preprint":false},{"pmid":"31718857","id":"PMC_31718857","title":"microRNA-132 inhibits osteogenic differentiation of periodontal ligament stem cells via GDF5 and the NF-κB signaling pathway.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/31718857","citation_count":30,"is_preprint":false},{"pmid":"30200326","id":"PMC_30200326","title":"Injured Achilles Tendons Treated with Adipose-Derived Stem Cells Transplantation and GDF-5.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30200326","citation_count":30,"is_preprint":false},{"pmid":"20937261","id":"PMC_20937261","title":"Combined use of bFGF and GDF-5 enhances the healing of medial collateral ligament injury.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20937261","citation_count":30,"is_preprint":false},{"pmid":"29761869","id":"PMC_29761869","title":"microRNA-665 promotes the proliferation and matrix degradation of nucleus pulposus through targeting GDF5 in intervertebral disc degeneration.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29761869","citation_count":30,"is_preprint":false},{"pmid":"23725396","id":"PMC_23725396","title":"Analysis of association between IL-1β, CASP-9, and GDF5 variants and low-back pain in Chinese male soldier: clinical article.","date":"2013","source":"Journal of neurosurgery. Spine","url":"https://pubmed.ncbi.nlm.nih.gov/23725396","citation_count":29,"is_preprint":false},{"pmid":"29146735","id":"PMC_29146735","title":"Reduced Dnmt3a increases Gdf5 expression with suppressed satellite cell differentiation and impaired skeletal muscle regeneration.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29146735","citation_count":28,"is_preprint":false},{"pmid":"29311146","id":"PMC_29311146","title":"Impact of broad regulatory regions on Gdf5 expression and function in knee development and susceptibility to osteoarthritis.","date":"2018","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29311146","citation_count":28,"is_preprint":false},{"pmid":"23226264","id":"PMC_23226264","title":"GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23226264","citation_count":28,"is_preprint":false},{"pmid":"16892395","id":"PMC_16892395","title":"A novel mutation in GDF5 causes autosomal dominant symphalangism in two Chinese families.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16892395","citation_count":28,"is_preprint":false},{"pmid":"19038017","id":"PMC_19038017","title":"A novel insertion mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene underlies Grebe-type chondrodysplasia in a consanguineous Pakistani family.","date":"2008","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19038017","citation_count":27,"is_preprint":false},{"pmid":"16014698","id":"PMC_16014698","title":"A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16014698","citation_count":27,"is_preprint":false},{"pmid":"33231490","id":"PMC_33231490","title":"Knockout of miR-21-5p alleviates cartilage matrix degradation by targeting Gdf5 in temporomandibular joint osteoarthritis.","date":"2020","source":"Bone & joint research","url":"https://pubmed.ncbi.nlm.nih.gov/33231490","citation_count":27,"is_preprint":false},{"pmid":"26739524","id":"PMC_26739524","title":"Adenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells.","date":"2016","source":"Journal of Zhejiang University. Science. B","url":"https://pubmed.ncbi.nlm.nih.gov/26739524","citation_count":27,"is_preprint":false},{"pmid":"19590978","id":"PMC_19590978","title":"A novel polymorphism of GDF5 gene and its association with body measurement traits in Bos taurus and Bos indicus breeds.","date":"2009","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19590978","citation_count":27,"is_preprint":false},{"pmid":"21976273","id":"PMC_21976273","title":"New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.","date":"2012","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21976273","citation_count":27,"is_preprint":false},{"pmid":"16222676","id":"PMC_16222676","title":"Du Pan syndrome phenotype caused by heterozygous pathogenic mutations in CDMP1 gene.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16222676","citation_count":26,"is_preprint":false},{"pmid":"38200442","id":"PMC_38200442","title":"Decellularized nucleus pulposus matrix/chitosan hybrid hydrogel combined with nucleus pulposus stem cells and GDF5-loaded microspheres for intervertebral disc degeneration prevention.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38200442","citation_count":26,"is_preprint":false},{"pmid":"30116367","id":"PMC_30116367","title":"BMP14 induces tenogenic differentiation of bone marrow mesenchymal stem cells in vitro.","date":"2018","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30116367","citation_count":25,"is_preprint":false},{"pmid":"31694926","id":"PMC_31694926","title":"An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse.","date":"2019","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31694926","citation_count":25,"is_preprint":false},{"pmid":"22905146","id":"PMC_22905146","title":"Positive selection on the osteoarthritis-risk and decreased-height associated variants at the GDF5 gene in East Asians.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22905146","citation_count":24,"is_preprint":false},{"pmid":"20683927","id":"PMC_20683927","title":"Mutations in GDF5 presenting as semidominant brachydactyly A1.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20683927","citation_count":24,"is_preprint":false},{"pmid":"25467786","id":"PMC_25467786","title":"Association between GDF5 rs143383 polymorphism and knee osteoarthritis: an updated meta-analysis based on 23,995 subjects.","date":"2014","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25467786","citation_count":23,"is_preprint":false},{"pmid":"14613311","id":"PMC_14613311","title":"Correlation of GDF5 and connexin 43 mRNA expression during embryonic development.","date":"2003","source":"The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/14613311","citation_count":22,"is_preprint":false},{"pmid":"23423687","id":"PMC_23423687","title":"Rs143383 in the growth differentiation factor 5 (GDF5) gene significantly associated with osteoarthritis (OA)-a comprehensive meta-analysis.","date":"2013","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23423687","citation_count":22,"is_preprint":false},{"pmid":"24582800","id":"PMC_24582800","title":"Growth and differentiation factor-5 (GDF-5) in the human intervertebral annulus cells and its modulation by IL-1ß and TNF-α in vitro.","date":"2014","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24582800","citation_count":22,"is_preprint":false},{"pmid":"27577507","id":"PMC_27577507","title":"Novel homozygous sequence variants in the GDF5 gene underlie acromesomelic dysplasia type-grebe in consanguineous families.","date":"2017","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/27577507","citation_count":21,"is_preprint":false},{"pmid":"16005596","id":"PMC_16005596","title":"Variable hand and foot abnormalities in family with congenital vertical talus and CDMP-1 gene mutation.","date":"2005","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/16005596","citation_count":20,"is_preprint":false},{"pmid":"35346361","id":"PMC_35346361","title":"Long non-coding RNA SNHG5 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-212-3p/GDF5/SMAD pathway.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35346361","citation_count":19,"is_preprint":false},{"pmid":"31338995","id":"PMC_31338995","title":"DNA hypermethylation of GDF5 in developmental dysplasia of the hip (DDH).","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31338995","citation_count":18,"is_preprint":false},{"pmid":"27030100","id":"PMC_27030100","title":"Mutant GDF5 enhances ameloblast differentiation via accelerated BMP2-induced Smad1/5/8 phosphorylation.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27030100","citation_count":18,"is_preprint":false},{"pmid":"30388100","id":"PMC_30388100","title":"The role of Gdf5 regulatory regions in development of hip morphology.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30388100","citation_count":18,"is_preprint":false},{"pmid":"24466161","id":"PMC_24466161","title":"Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24466161","citation_count":18,"is_preprint":false},{"pmid":"25757091","id":"PMC_25757091","title":"Association of GDF5, SMAD3 and RUNX2 polymorphisms with temporomandibular joint osteoarthritis in female Han Chinese.","date":"2015","source":"Journal of oral rehabilitation","url":"https://pubmed.ncbi.nlm.nih.gov/25757091","citation_count":18,"is_preprint":false},{"pmid":"11862461","id":"PMC_11862461","title":"Gdf5 is expressed in the developing skeleton of median fins of late-stage zebrafish, Danio rerio.","date":"2001","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/11862461","citation_count":17,"is_preprint":false},{"pmid":"21281725","id":"PMC_21281725","title":"Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus.","date":"2011","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/21281725","citation_count":17,"is_preprint":false},{"pmid":"12687891","id":"PMC_12687891","title":"Grebe dysplasia and the spectrum of CDMP1 mutations.","date":"2003","source":"Pediatric pathology & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12687891","citation_count":16,"is_preprint":false},{"pmid":"34203285","id":"PMC_34203285","title":"Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34203285","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53276,"output_tokens":9107,"usd":0.148217,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19192,"output_tokens":8565,"usd":0.155042,"stage2_stop_reason":"end_turn"},"total_usd":0.303259,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"A point mutation in CDMP1/GDF5 substituting the first conserved cysteine in the mature active domain produces a protein that is not secreted and is inactive in vitro; it exerts a dominant-negative effect by preventing secretion of other related BMP family members, proposed to occur through heterodimer formation.\",\n      \"method\": \"In vitro secretion assay, functional activity assay, dominant-negative analysis in cell culture\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro secretion and activity assays plus dominant-negative functional test in single study; heterodimer mechanism proposed but not fully reconstituted\",\n      \"pmids\": [\"9288098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GDF5 is necessary and sufficient for cartilage development and restriction of joint formation to appropriate locations in the digits; recombinant GDF5 protein applied to developing chick and mouse limbs promotes cartilage growth and defines joint-forming boundaries, linking cartilage and joint development.\",\n      \"method\": \"Recombinant protein bead implantation in chick and mouse limb buds; genetic analysis of brachypodism mutants; in vivo loss-of-function and gain-of-function\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal loss-of-function (brachypodism mutants) and gain-of-function (protein bead implantation) experiments replicated across two species\",\n      \"pmids\": [\"10208739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The BMP antagonist Noggin binds to GDF5 and inhibits all observed effects of GDF5 in vivo (cartilage growth, digit morphogenesis); BMP-7 negatively regulates Gdf5 gene expression in joint-forming regions; Noggin treatment induces ectopic Gdf5 expression in interdigital mesoderm.\",\n      \"method\": \"In vivo chick bead implantation with Noggin; in situ hybridization; retroviral misexpression of Hedgehog signals\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo binding-consequence experiment and expression regulation demonstrated in single study with multiple approaches\",\n      \"pmids\": [\"9918693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BMPR1B (ALK6) is the physiological type I receptor transducing GDF5 signal for digit cartilage formation; GDF5 acts through both BMPR1B-dependent and -independent processes; epistasis analysis shows BMPR1B regulates chondrogenesis and segmentation partly through GDF5 and partly independently, and GDF5 can signal through type I receptors other than BMPR1B.\",\n      \"method\": \"Mouse insertional mutant (BmprIB regulatory allele), double mutant genetic epistasis (Gdf5 x BmprIB), expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with compound mutants in mice, complementary expression analyses\",\n      \"pmids\": [\"10631181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GDF5 acts at two stages of skeletal development: first it promotes chondrogenic cell condensation by increasing cell adhesion; second, it increases skeletal element size by stimulating cell proliferation in epiphyseal cartilage. Retroviral overexpression of GDF5 in chick limb increased element size and S-phase cells; in vitro micromass cultures showed increased cell adhesiveness.\",\n      \"method\": \"Retroviral overexpression (RCAS) in chick embryo, autoradiography (S-phase labeling), micromass and single-cell suspension cultures of limb mesenchyme\",\n      \"journal\": \"The Journal of bone and joint surgery. American volume\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo overexpression plus in vitro functional assays in single study with two orthogonal approaches\",\n      \"pmids\": [\"11263662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Members of the GDF5/6/7 subgroup are expressed in distinct subsets of developing joints and are required for joint, ligament, and cartilage formation at different skeletal sites; Gdf5 and Gdf6 double mutants show additive/synergistic defects, establishing functional redundancy and distinct spatial roles within the subgroup.\",\n      \"method\": \"Single and double null mouse mutant analysis, skeletal phenotyping\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous double-knockout epistasis in mice with comprehensive skeletal phenotyping\",\n      \"pmids\": [\"12606286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ror2 (tyrosine kinase receptor) and BMPR1B (BRI-b, serine/threonine kinase receptor) form a ligand-independent heteromeric complex; the frizzled-like CRD domain of Ror2 is required for this complex; within the complex Ror2 is transphosphorylated by BMPR1B; Ror2 modulates GDF5 signaling by inhibiting Smad1/5 signaling and activating a Smad-independent pathway, both required for chondrogenic differentiation. Epistatic interactions in Ror2, BMPR1B, and Gdf5 compound mutant mice confirm in vivo functional interaction.\",\n      \"method\": \"Co-immunoprecipitation, domain-deletion mutants, phosphorylation assays, Smad reporter assays, ATDC5 chondrogenesis assay, compound mutant mouse genetics\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal Co-IP, phosphorylation assay, reporter assay, and in vivo epistasis in compound mutant mice\",\n      \"pmids\": [\"15569154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GDF5 and BMP4 have distinct functions during chondrogenesis: GDF5 increases the number of prechondrogenic condensations and cartilaginous nodules without altering overall differentiation pattern, and causes sustained elevated Sox9 expression and only transient Col10 upregulation; BMP4 is instructive and induces mesenchymal cells toward the chondrogenic lineage with accelerated maturation.\",\n      \"method\": \"Mouse embryonic limb bud micromass culture with recombinant protein treatment, gene expression analysis, histology\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic comparative micromass culture with multiple markers in single study\",\n      \"pmids\": [\"15048875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GDF5 L441P mutation causes brachydactyly type A2 by abolishing binding to both BMPR1A and BMPR1B ectodomains (loss of function); GDF5 R438L mutation causes symphalangism by acquiring increased binding to BMPR1A (normally BMP2's receptor) while retaining normal BMPR1B binding — a gain of BMP2-like receptor-binding specificity; both mutants show normal Noggin binding. This identifies key receptor-binding specificity determinants in GDF5.\",\n      \"method\": \"Biosensor (SPR) interaction analyses with receptor ectodomains, recombinant protein expression, limb bud micromass culture, ATDC5 and C2C12 cell treatment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative SPR binding assays plus functional cell-based assays for two distinct mutations, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"16127465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GDF5 binds specifically to BMPR1b, BMPR2, and ACTR2a receptors; GDF5 induces phosphorylation of Smad1/5/8 and their nuclear translocation, upregulating ID1 and ID3 expression via a Smad-dependent, MAPK-independent pathway in human vascular smooth muscle cells; GDF5 also has chemotactic activity partially dependent on Smad1 and ID1.\",\n      \"method\": \"Receptor expression analysis, Smad phosphorylation assay, Smad1 siRNA knockdown, ID1/ID3 reporter/expression assays, p38/ERK inhibitors, chemotaxis assay in HUVSMC\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown, specific inhibitors, and phosphorylation assays in single study\",\n      \"pmids\": [\"16716349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF5 N445K and N445T mutations found in multiple synostosis syndrome patients confer resistance to the BMP inhibitor Noggin and altered signaling, causing gain of chondrogenic function. Residue N445 is a key determinant of Noggin sensitivity; BMP9 and BMP10, which naturally have lysine at this position, are also insensitive to Noggin. Swapping two additional residues was required to render BMP9 Noggin-sensitive, demonstrating that this residue is part of the antagonist interface.\",\n      \"method\": \"Patient mutation identification, functional studies in chicken micromass culture, ectopic cartilage induction in chick in vivo, sequence and structural comparison\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo chick model plus in vitro functional assays, site-directed mutagenesis approach, and structural reasoning corroborated across multiple mutants\",\n      \"pmids\": [\"19956691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GDF5 and BMP2 prevent apoptosis in mouse embryonic fibroblasts (but not smooth muscle cells) via BMPR2; both factors stimulate interaction of BMPR2 with XIAP, reducing XIAP ubiquitination and increasing XIAP protein stability, which then inactivates caspases. This anti-apoptotic mechanism is independent of Smad and MAPK signaling.\",\n      \"method\": \"Apoptosis assay, Co-IP of BMPR2 with XIAP, ubiquitination assay, caspase activity assay, in isolated MEFs and SMCs\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination, and functional apoptosis assays in single study with multiple orthogonal methods\",\n      \"pmids\": [\"19782107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF5 promotes chondrogenesis downstream of BMPR1B (ALK6)/Alk6 signaling; Trps1 protein levels and nuclear translocation are upregulated by GDF5 treatment in a dose-dependent manner via Alk6 and p38 MAPK signaling; Trps1 acts downstream of GDF5 to promote chondrocyte differentiation and apoptosis, and also suppresses Gdf5 expression in a negative feedback loop.\",\n      \"method\": \"GDF5 protein treatment of ATDC5 cells, dominant-negative Alk6 (dn-Alk6) inhibition, p38 MAPK inhibitor (SB203580), Trps1 overexpression and knockdown, Western blot, immunofluorescence\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacologic inhibitors plus gain/loss-of-function in single study\",\n      \"pmids\": [\"18363966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The OA-risk T allele of rs143383 in the GDF5 5'-UTR mediates reduced GDF5 expression in all joint tissues tested (cartilage, synovium, ligament), demonstrating a joint-wide cis-regulatory effect; a second 3'-UTR polymorphism influences allelic expression of GDF5 independent of rs143383; DEAF-1 protein binds differentially to the two alleles of rs143383 (trans-acting factor).\",\n      \"method\": \"Allelic expression imbalance assay in patient tissue, luciferase reporter assay, electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — allelic expression in multiple tissue types, EMSA for trans-factor binding, single lab\",\n      \"pmids\": [\"19565498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DNA methylation of the GDF5 promoter and 5'-UTR regulates GDF5 expression; demethylation correlates with increased GDF5 expression; the CpG sites created by the C alleles of rs143383 and rs143384 are variably methylated; demethylating agent treatment of a heterozygous cell line further increases allelic expression imbalance between C and T alleles, demonstrating epigenetic modulation of the rs143383 genetic effect.\",\n      \"method\": \"Bisulfite methylation analysis, demethylating agent (5-aza-2'-deoxycytidine) treatment, allelic expression quantification in cell lines and joint tissues\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — methylation analysis plus pharmacological manipulation in cell lines and patient tissue, single lab\",\n      \"pmids\": [\"21642387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Sp1, Sp3, P15, and DEAF-1 are trans-acting factors that bind to the GDF5 5'-UTR at rs143383; Sp1, Sp3, and DEAF-1 are repressors of GDF5 expression; DEAF-1 preferentially represses the T allele of rs143383 relative to the C allele, contributing to differential allelic expression; Sp1 and DEAF-1 in combination show greatest repressive activity.\",\n      \"method\": \"Competition and supershift EMSA, oligonucleotide pulldown with quantitative mass spectrometry, chromatin immunoprecipitation (ChIP), RNA interference (siRNA knockdown), overexpression assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (EMSA, MS proteomics, ChIP, RNAi, overexpression) all converging on same trans-factor identification in single rigorous study\",\n      \"pmids\": [\"23825960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SOX11 directly activates GDF5 expression by binding to conserved SOX family binding sites in the GDF5 5'-UTR, as demonstrated by in vitro and micromass culture overexpression; SOX11 misexpression in developing chick limbs via RCAS virus enhances but does not ectopically induce Gdf5 expression.\",\n      \"method\": \"SOX11 overexpression in vitro and in micromass cultures, RCAS retroviral infection in chick limb, reporter/expression assays, binding site identification\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding site identification, gain-of-function in vitro and in vivo, single lab\",\n      \"pmids\": [\"23356643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDF5 stimulation of human chondrocytes inhibits expression of catabolic enzymes MMP13 and ADAMTS4, and upregulates anabolic genes ACAN and SOX9; this is mediated through upregulation of Wnt inhibitors DKK1 and FRZB, and MMP13 inhibition is specifically dependent on DKK1 (blocking canonical Wnt signaling).\",\n      \"method\": \"Human chondrocyte pellet culture, qPCR, ELISA for protein levels, Wnt3a and CHIR-99021 stimulation, DKK1 inhibitor (WAY-262611) co-treatment\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with multiple growth factor doses and inhibitors in primary human cells, single lab\",\n      \"pmids\": [\"24561281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CpG methylation at the +37 site (4 bp upstream of rs143383) within the SP1/SP3 binding site has an allele-specific effect: methylation at this site attenuates SP1, SP3, and DEAF-1 repression of GDF5 promoter activity, and modulates the level and direction of allelic imbalance at rs143383. OA knee cartilage shows greater demethylation at +37 compared with hip cartilage, potentially explaining the knee-specific OA association.\",\n      \"method\": \"Bisulfite sequencing of normal and OA cartilage, methylation-sensitive EMSA for SP1/SP3 binding, luciferase promoter reporter assays with methylated constructs\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and reporter assays with methylated vs unmethylated templates, patient tissue analysis, single lab\",\n      \"pmids\": [\"24861163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"YY1 is a trans-acting activator of GDF5: it differentially binds to the alleles of a -41 bp promoter variant (more avidly to the A allele), and YY1 knockdown significantly reduces GDF5 expression; the A allele at -41 bp compensates for reduced expression mediated by the T allele of rs143383, identifying a regulatory site that can be manipulated to modulate GDF5 expression.\",\n      \"method\": \"Luciferase reporter assay, EMSA, YY1 siRNA knockdown\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and functional reporter plus siRNA knockdown in single study\",\n      \"pmids\": [\"22929025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDF5 and BMP2 induce neurite outgrowth in SH-SY5Y human neuronal cells via a direct neuronal mechanism (not indirect glial effect), dependent on BMP type I receptor activation of canonical Smad1/5/8 signaling.\",\n      \"method\": \"SH-SY5Y cell culture with GDF5 and BMP2, Smad1/5/8 phosphorylation assay, BMP receptor activation assay\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited mechanistic dissection (pathway inhibition not fully detailed in abstract)\",\n      \"pmids\": [\"23831389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GDF5 acts as a context-dependent BMP-2 antagonist: in C2C12 cells (but not ATDC5 cells), GDF5 and its BMPR-IA-binding variant GDF5 R57A antagonize BMP2-mediated ALP expression even when signaling occurs solely via BMPR-IA; this context-dependency suggests an additional unidentified GDF5-specific co-receptor modulates signaling output.\",\n      \"method\": \"ALP assay in ATDC5 and C2C12 cells, in vivo heterotopic implantation in mice, crystal structure comparison of GDF5 R57A:BMPR-IA and BMP2:BMPR-IA complexes\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — crystal structure plus in vitro functional assay plus in vivo heterotopic implant; antagonism mechanism inferred but co-receptor not identified\",\n      \"pmids\": [\"26385096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The crystal structure of Gremlin-2 (a DAN-family BMP antagonist) bound to GDF5 at 2.9-Å resolution reveals two Grem2 dimers binding perpendicularly to each GDF5 monomer in an H-like structure; upon complex formation, the dynamic N-terminus of Grem2 undergoes significant conformational change to simultaneously interact with both type I and type II receptor motifs on GDF5. DAN-family members can interact with BMP-type I receptor complexes (unlike Noggin which outcompetes the type I receptor), and Grem2-GDF5 forms a stable aggregate-like structure in vitro.\",\n      \"method\": \"X-ray crystallography (2.9-Å resolution), binding studies (SPR/biochemical), structural comparison with unbound Grem2\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional binding validation; mechanistic conclusions directly from structural data\",\n      \"pmids\": [\"27524626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gdf5-positive interzone cells continuously influx into developing joints rather than arising from a single early set of progenitors; using a knockin Gdf5-CreERT2 mouse, early labeling of Gdf5+ cells failed to mark the entire joint, while multiple sequential Cre activation steps showed progressive contribution to various joint compartments; spatiotemporal differences in Gdf5 expression may instruct lineage divergence into different joint tissues.\",\n      \"method\": \"Gdf5-CreERT2 knockin mouse lineage tracing, inducible Cre activation at multiple time points, tdTomato reporter\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous inducible lineage-tracing with temporal resolution using knockin mouse model\",\n      \"pmids\": [\"27292641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Separate modular enhancers distributed over >100 kb of the Gdf5 locus (including upstream and downstream regions) control expression in distinct joint subsets (axial vs. limb, proximal vs. distal, specific sub-joints like elbow); predicted transcription factor binding sites within these enhancers are required for expression in particular joints; functional rescue in mice confirmed large flanking regions are required for normal joint formation.\",\n      \"method\": \"Transgenic mouse enhancer reporter assays, systematic locus survey, functional rescue tests in Gdf5 mutant mice\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic in vivo enhancer mapping with functional rescue in mice, multiple enhancers validated\",\n      \"pmids\": [\"27902701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A novel growth enhancer (GROW1) downstream of Gdf5 controls expression at the growing ends of long bones (not joints); GROW1 is required for normal Gdf5 expression at bone ends and normal bone lengths in vivo; a common human base-pair change in GROW1 decreases enhancer activity; the derived allele colocalizes with signatures of positive selection in Neandertals, Denisovans, and non-African humans.\",\n      \"method\": \"Transgenic mouse enhancer assays, GROW1 deletion in vivo, human variant functional reporter assay, population genetics analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo enhancer deletion plus reporter assays plus in vivo bone length phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"28671685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The embryonic CaVβ1 isoform (CaVβ1E) boosts GDF5 expression downstream of its induction by muscle denervation; CaVβ1E overexpression improves muscle mass wasting in aging mice by increasing GDF5 expression; loss of CaVβ1E in aged muscle is associated with attenuated GDF5-dependent response to denervation.\",\n      \"method\": \"CaVβ1E overexpression mouse model, sciatic denervation model, CaVβ1E knockout in aging, GDF5 expression measurement\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss- and gain-of-function in mice with defined phenotypic readout; pathway placement via epistasis-like approach\",\n      \"pmids\": [\"31694926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gdf5 progenitors in the enthesis give rise to fibrocartilage cells that mineralize via hedgehog signaling; hedgehog (Hh) pathway is required for enthesis mineralization, as tissue-specific deletion of Smoothened (the obligate Hh transducer) in tendon/enthesis cells leads to significant reductions in mineralized fibrocartilage apposition.\",\n      \"method\": \"Gdf5-Cre lineage tracing, tissue-specific Smoothened conditional knockout, histology, immunohistochemistry\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic lineage tracing plus conditional knockout with defined cellular phenotype\",\n      \"pmids\": [\"26141957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GDF5 W408R mutation (identified by ENU mutagenesis in mice) is secreted and dimerizes normally but inhibits wild-type GDF5 function in a dominant-negative fashion, causing brachypodism, ankylosis and early-onset osteoarthritis; the mutation resides in a highly conserved region of the active signaling domain.\",\n      \"method\": \"ENU mutagenesis screen, heterozygous/homozygous phenotypic analysis, dominant-negative functional assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model with dominant-negative functional validation, single lab\",\n      \"pmids\": [\"17656374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GDF5 S94N mutation (in the knuckle epitope/BMPRII interaction site) impairs binding to BMPRII, reducing Smad and non-Smad signaling and reducing chondrogenic differentiation of ATDC5 cells; paradoxically, the mutation strongly enhances chondrogenesis in mouse micromass cultures because of strongly reduced affinity for Noggin, resulting in gain of function by escaping Noggin inhibition.\",\n      \"method\": \"SPR quantitative binding assays, reporter gene assay, ALP assay, qPCR, ATDC5 cell differentiation assay, mouse micromass culture\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative SPR binding, reporter assays, and functional differentiation assays with multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"21976273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDF5 W414R mutation simultaneously causes gain and loss of function: insensitivity to Noggin (gain of function, causing SYNS2) and reduced signaling specifically via BMPR1A (loss of function, causing BDA1). SPR analysis confirmed altered receptor and antagonist binding affinities for this single mutation.\",\n      \"method\": \"Primary mesenchymal cell chondrogenesis assay, luciferase reporter assay, Surface Plasmon Resonance (SPR) binding analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — SPR quantitative binding plus reporter assays plus functional chondrogenesis assay in single rigorous study demonstrating dual mechanism\",\n      \"pmids\": [\"24098149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BMP14/GDF5 induces tenogenic differentiation of bone marrow mesenchymal stem cells by upregulating scleraxis, tenomodulin, and Sirt1; BMP14 triggers JNK and Smad1 phosphorylation; Sirt1 deacetylates PPARγ to promote tenogenic differentiation; Sirt1 gain/loss-of-function promotes/inhibits tenogenic differentiation; JNK and Smad1 inhibition increased PPARγ acetylation and inhibited tenogenic markers, defining the BMP14-Sirt1-JNK/Smad1-PPARγ tenogenic differentiation pathway.\",\n      \"method\": \"BMSCs treated with BMP14, Sirt1 overexpression and knockdown, JNK and Smad inhibitors, acetylation assay, qPCR and Western blot\",\n      \"journal\": \"Experimental and therapeutic medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss-of-function plus pathway inhibition with multiple readouts in single study\",\n      \"pmids\": [\"30116367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gdf5 expression is upregulated in articular cartilage following experimental OA (destabilization of medial meniscus) and after acute cartilage injury; expression in injured synovium inversely correlates with YAP (Yes-associated protein) expression; overexpression of YAP suppresses Gdf5 expression in chondroprogenitors in vitro; Gdf5 upregulation in both injury models requires regulatory sequence downstream of Gdf5 coding exons.\",\n      \"method\": \"Gdf5-LacZ reporter mouse, DMM experimental OA model, acute cartilage injury model, immunohistochemistry, YAP overexpression in vitro, microarray analysis of human OA cartilage\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo reporter mice plus in vitro YAP overexpression plus required regulatory sequence identified; single lab\",\n      \"pmids\": [\"31932746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GDF5 intervertebral disc cells express BMPR1A, BMPR1B, and BMPR2 receptors relevant for GDF5 action; adenoviral GDF5 gene transfer produces two secreted forms consistent with activated GDF5 dimer and proform; overexpressed GDF5 is bioactive and promotes growth of rabbit disc cells.\",\n      \"method\": \"Adenoviral gene transfer, western blot (two GDF5 forms), ELISA, [3H]thymidine proliferation assay, receptor expression analysis\",\n      \"journal\": \"Journal of molecular medicine (Berlin, Germany)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — receptor identification and growth assay but limited mechanistic depth, single lab\",\n      \"pmids\": [\"14669002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TGF-β1 and GDF5 synergistically drive differentiation of human adipose stromal cells toward nucleus pulposus-like cells; the Smad2/3 pathway mainly governs acquisition of NP cell molecular identity while the Smad1/5/8 pathway controls NP cell morphology.\",\n      \"method\": \"hASC culture with growth factors, gene expression analysis, extracellular matrix assessment, in vivo transplantation in nude mice, Smad pathway analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pathway attribution based on expression/signaling analysis without specific inhibitors fully detailed in abstract\",\n      \"pmids\": [\"26661057\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GDF5 (also known as CDMP1/BMP14) is a secreted BMP-family ligand that preferentially binds the type I receptor BMPR1B (with secondary signaling through BMPR1A and BMPR2) to activate canonical Smad1/5/8 signaling, and is antagonized by Noggin (which blocks both type I and type II receptor-binding epitopes) and DAN-family antagonists like Gremlin-2 (which bind receptor interfaces via a distinct H-shaped structure); it drives joint formation, chondrogenesis, and skeletal patterning through modular tissue-specific enhancers and is modulated at the transcriptional level by methylation of CpG sites in its 5'-UTR and by trans-acting repressors (Sp1, Sp3, DEAF-1) and activators (YY1, SOX11); disease-causing mutations alter receptor-binding specificity (gain of BMPR1A binding causing symphalangism) or Noggin-binding resistance (causing multiple synostosis syndrome), while loss-of-function mutations cause brachydactylies and acromesomelic dysplasias; beyond the skeleton, GDF5 promotes tenogenic differentiation via a Sirt1-JNK/Smad1-PPARγ pathway, supports dopaminergic neuron survival via Smad signaling, and inhibits cartilage catabolism by inducing DKK1-mediated Wnt pathway suppression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GDF5 (CDMP1/BMP14) is a secreted BMP-family ligand that is necessary and sufficient for cartilage growth and for restricting joint formation to its correct positions in the developing skeleton [#1]. It acts at sequential stages of skeletal development, first promoting chondrogenic cell condensation through increased cell adhesion and then driving epiphyseal cell proliferation to set skeletal element size [#4], and it lineage-marks the continuously recruited interzone cells that build joint compartments and entheseal fibrocartilage [#23, #27]. GDF5 signals principally through the type I receptor BMPR1B (ALK6) to activate canonical Smad1/5/8 phosphorylation and downstream targets such as ID1/ID3 and Trps1, while also engaging BMPR1A, BMPR2 and Smad-independent (p38, non-Smad) routes [#3, #9, #12]; its output is further shaped by a ligand-independent BMPR1B–Ror2 heteromeric complex that tunes chondrogenic differentiation [#6]. Ligand activity is held in check by the antagonist Noggin, which blocks GDF5 effects in vivo [#2], and by DAN-family antagonist Gremlin-2, whose crystal structure with GDF5 reveals an H-shaped assembly that occludes both type I and type II receptor motifs [#22]. Disease-causing mutations partition cleanly by mechanism: substitutions that abolish or remodel receptor-binding specificity cause brachydactyly and symphalangism (e.g. L441P loss of BMPR1A/B binding; R438L gain of BMPR1A binding) [#8], residues at the Noggin interface (N445, W414, S94) confer antagonist resistance producing synostosis or gain-of-function chondrogenesis [#10, #29, #30], and dominant-negative alleles that disrupt secretion or signaling cause brachydactyly, ankylosis and early osteoarthritis [#0, #28]. GDF5 expression is governed by a >100 kb array of modular tissue-specific enhancers, including the GROW1 long-bone enhancer carrying a positively selected human variant [#24, #25], and is fine-tuned at the 5'-UTR by CpG methylation and by trans-acting repressors (Sp1, Sp3, DEAF-1) and activators (YY1, SOX11), with the osteoarthritis-risk rs143383 T allele lowering joint-wide GDF5 expression [#13, #15, #19, #16, #18]. Beyond the skeleton, GDF5 suppresses cartilage catabolism by inducing DKK1-mediated inhibition of canonical Wnt signaling [#17], drives tenogenic differentiation via a Sirt1-JNK/Smad1-PPARγ axis [#31], and stabilizes XIAP through BMPR2 to confer Smad-independent anti-apoptotic protection [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that GDF5 must be secreted as an active dimer to function and that a cysteine-disrupting mutation acts dominant-negatively, hinting that GDF5 can heterodimerize with related BMP ligands.\",\n      \"evidence\": \"In vitro secretion and activity assays with dominant-negative analysis in cell culture\",\n      \"pmids\": [\"9288098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterodimer formation proposed but not biochemically reconstituted\", \"Receptor engagement not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined GDF5 as both necessary and sufficient for cartilage growth and for positioning joints, placing it at the center of skeletal patterning.\",\n      \"evidence\": \"Recombinant protein bead implantation in chick/mouse limbs plus brachypodism mutant genetics\",\n      \"pmids\": [\"10208739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor and intracellular signaling not yet defined\", \"Did not separate proliferative from condensation effects\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed GDF5 activity is extracellularly antagonized by Noggin and that GDF5 expression is itself patterned by BMP7 and Hedgehog inputs.\",\n      \"evidence\": \"In vivo chick Noggin bead implantation, in situ hybridization, retroviral misexpression\",\n      \"pmids\": [\"9918693\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Noggin binding interface on GDF5 not mapped\", \"Direct vs indirect BMP7 regulation unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified BMPR1B (ALK6) as the physiological type I receptor for GDF5 in digit chondrogenesis while revealing BMPR1B-independent GDF5 actions.\",\n      \"evidence\": \"Gdf5 x BmprIB compound mutant genetic epistasis in mice\",\n      \"pmids\": [\"10631181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of alternative type I receptors not pinned down\", \"Downstream Smad effectors not directly traced\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved GDF5 into two temporally distinct skeletal functions: increasing cell adhesion during condensation and stimulating epiphyseal proliferation to set element size.\",\n      \"evidence\": \"RCAS overexpression in chick, S-phase autoradiography, micromass adhesion assays\",\n      \"pmids\": [\"11263662\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of adhesion increase unknown\", \"Receptor coupling to each stage not dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Distinguished GDF5 from BMP4 functionally, showing GDF5 expands prechondrogenic condensations and sustains Sox9 without driving lineage instruction or full maturation.\",\n      \"evidence\": \"Comparative limb bud micromass culture with recombinant proteins and marker analysis\",\n      \"pmids\": [\"15048875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor-level basis of the functional divergence unclear\", \"Single culture system\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealed that a ligand-independent BMPR1B–Ror2 heteromeric complex modulates GDF5 signaling, balancing Smad inhibition against a Smad-independent pathway during chondrogenesis.\",\n      \"evidence\": \"Reciprocal Co-IP, domain deletions, phosphorylation/reporter assays, ATDC5, compound mutant mice\",\n      \"pmids\": [\"15569154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Smad-independent effector not defined\", \"Stoichiometry of the complex unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Provided early evidence that GDF5 receptors are present on intervertebral disc cells and that recombinant GDF5 dimer is bioactive on disc tissue.\",\n      \"evidence\": \"Adenoviral GDF5 gene transfer, Western blot, proliferation assay in rabbit disc cells\",\n      \"pmids\": [\"14669002\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Limited mechanistic depth and single lab\", \"Signaling pathway not dissected\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapped receptor-binding specificity determinants by showing brachydactyly and symphalangism mutations selectively abolish or acquire type I receptor binding while sparing Noggin binding.\",\n      \"evidence\": \"SPR binding to receptor ectodomains plus micromass and cell-based functional assays\",\n      \"pmids\": [\"16127465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of specificity switch not crystallographically resolved here\", \"In vivo recapitulation of human phenotypes limited\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Confirmed GDF5 activates canonical Smad1/5/8 signaling through BMPR1b/BMPR2/ACTR2a inducing ID1/ID3 in a Smad-dependent, MAPK-independent manner, and added a chemotactic function.\",\n      \"evidence\": \"Receptor expression analysis, Smad1 siRNA, ID reporters, MAPK inhibitors, chemotaxis in HUVSMC\",\n      \"pmids\": [\"16716349\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Vascular smooth muscle context only\", \"Chemotaxis mechanism partially defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed a secretion-competent, normally dimerizing GDF5 mutation (W408R) acts dominant-negatively in vivo, causing brachypodism, ankylosis and early osteoarthritis.\",\n      \"evidence\": \"ENU mutagenesis mouse model with dominant-negative functional validation\",\n      \"pmids\": [\"17656374\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular interference mechanism not biochemically defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placed Trps1 downstream of GDF5/ALK6–p38 signaling as a driver of chondrocyte differentiation and as a negative feedback repressor of Gdf5.\",\n      \"evidence\": \"GDF5 treatment of ATDC5, dn-Alk6, p38 inhibitor, Trps1 gain/loss-of-function\",\n      \"pmids\": [\"18363966\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of Trps1 feedback not tested\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a Smad/MAPK-independent anti-apoptotic mechanism in which GDF5 promotes BMPR2–XIAP interaction, stabilizing XIAP to inactivate caspases.\",\n      \"evidence\": \"Apoptosis, Co-IP, ubiquitination and caspase assays in MEFs vs SMCs\",\n      \"pmids\": [\"19782107\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type specificity unexplained\", \"Physiological context beyond cultured fibroblasts unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated the osteoarthritis-risk rs143383 T allele lowers GDF5 expression joint-wide and that DEAF-1 binds the variant differentially, establishing a cis/trans regulatory disease axis.\",\n      \"evidence\": \"Allelic expression imbalance in patient tissue, luciferase reporters, EMSA\",\n      \"pmids\": [\"19565498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full trans-factor repertoire not yet defined\", \"Causal chain to cartilage degeneration not proven\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified N445 as a Noggin-sensitivity determinant, showing synostosis mutations confer Noggin resistance and gain of chondrogenic function.\",\n      \"evidence\": \"Patient mutations, chick micromass and in vivo cartilage induction, structural sequence comparison\",\n      \"pmids\": [\"19956691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystallographic definition of the antagonist interface awaited\", \"Additional residues only inferred from BMP9 swaps\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed DNA methylation of the GDF5 5'-UTR modulates expression and that allele-created CpG sites couple epigenetic state to the rs143383 genetic effect.\",\n      \"evidence\": \"Bisulfite analysis, demethylating agent treatment, allelic expression quantification\",\n      \"pmids\": [\"21642387\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Enzymes setting methylation marks not identified\", \"Causal directionality in OA tissue unproven\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed a single S94N mutation causing reduced BMPR2 binding paradoxically enhances chondrogenesis by escaping Noggin, illustrating coupled receptor and antagonist interfaces.\",\n      \"evidence\": \"SPR binding, reporter, ALP, qPCR, ATDC5 and mouse micromass assays\",\n      \"pmids\": [\"21976273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo phenotype of S94N not established\", \"Context-dependence across cell types only partly explored\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified YY1 as a trans-activator binding a -41 bp promoter variant that can compensate for the OA-risk rs143383 T allele.\",\n      \"evidence\": \"Luciferase reporter, EMSA, YY1 siRNA knockdown\",\n      \"pmids\": [\"22929025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo contribution of YY1 to joint GDF5 not shown\", \"Interaction with repressors not modeled\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved the trans-acting regulatory network at rs143383, identifying Sp1/Sp3/DEAF-1 as repressors with allele-selective DEAF-1 activity contributing to differential expression.\",\n      \"evidence\": \"EMSA, oligo pulldown mass spectrometry, ChIP, RNAi, overexpression\",\n      \"pmids\": [\"23825960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial logic with activators not fully integrated\", \"Tissue specificity of factor occupancy not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified SOX11 as a direct activator of GDF5 via conserved 5'-UTR SOX sites, enhancing but not ectopically inducing expression.\",\n      \"evidence\": \"SOX11 overexpression in vitro and in chick micromass/limb, binding site analysis\",\n      \"pmids\": [\"23356643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Requirement of SOX11 for endogenous Gdf5 not demonstrated by loss-of-function\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined a chondroprotective output: GDF5 suppresses catabolic MMP13/ADAMTS4 and raises anabolic ACAN/SOX9 via DKK1/FRZB-mediated inhibition of canonical Wnt signaling.\",\n      \"evidence\": \"Human chondrocyte pellet culture, qPCR/ELISA, Wnt agonists and DKK1 inhibitor\",\n      \"pmids\": [\"24561281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of the GDF5-DKK1-Wnt axis lacking\", \"Receptor route to DKK1 induction not traced\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided initial evidence that GDF5 induces neurite outgrowth in human neuronal cells through direct BMP type I receptor–Smad1/5/8 signaling.\",\n      \"evidence\": \"SH-SY5Y culture, Smad1/5/8 phosphorylation and receptor activation assays\",\n      \"pmids\": [\"23831389\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pathway dissection limited and not confirmed by inhibitors in detail\", \"Single cell line, single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed a single W414R mutation produces simultaneous gain (Noggin insensitivity, SYNS2) and loss (reduced BMPR1A signaling, BDA1) of function, unifying two disease mechanisms in one residue.\",\n      \"evidence\": \"Mesenchymal chondrogenesis assay, luciferase reporter, SPR binding\",\n      \"pmids\": [\"24098149\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dual effect not crystallized here\", \"In vivo dual phenotype recapitulation not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked epigenetics to allelic regulation by showing methylation at the +37 SP1/SP3 site attenuates repression and that joint-specific demethylation may underlie knee-selective OA association.\",\n      \"evidence\": \"Bisulfite sequencing of OA cartilage, methylation-sensitive EMSA, methylated reporter assays\",\n      \"pmids\": [\"24861163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of joint-specific demethylation unknown\", \"Causality vs correlation in OA not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed GDF5+ enthesis progenitors give rise to fibrocartilage that mineralizes through Hedgehog signaling, extending GDF5 lineage roles to tendon-bone attachment.\",\n      \"evidence\": \"Gdf5-Cre lineage tracing with Smoothened conditional knockout\",\n      \"pmids\": [\"26141957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of GDF5 ligand itself (vs lineage marker) in enthesis not isolated\", \"Hh-GDF5 crosstalk not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated GDF5 can act as a context-dependent BMP2 antagonist even through BMPR-IA, implying an unidentified GDF5-specific co-receptor shapes signaling output.\",\n      \"evidence\": \"ALP assays in ATDC5/C2C12, heterotopic implantation, crystal structures of GDF5 R57A:BMPR-IA\",\n      \"pmids\": [\"26385096\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The proposed co-receptor was not identified\", \"Antagonism mechanism inferred rather than reconstituted\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed GDF5 synergizes with TGF-β1 to differentiate human adipose stromal cells toward nucleus pulposus cells, with Smad2/3 controlling identity and Smad1/5/8 controlling morphology.\",\n      \"evidence\": \"hASC culture, gene/ECM analysis, in vivo transplant, Smad pathway analysis\",\n      \"pmids\": [\"26661057\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pathway attribution lacked specific inhibitor confirmation\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided lineage-tracing evidence that joints are built by continuous influx of Gdf5+ interzone cells rather than a fixed early progenitor pool.\",\n      \"evidence\": \"Gdf5-CreERT2 knockin inducible lineage tracing at multiple timepoints\",\n      \"pmids\": [\"27292641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals directing lineage divergence into joint tissues unknown\", \"Molecular heterogeneity of influxing cells uncharacterized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Determined the Gremlin-2:GDF5 crystal structure, showing an H-shaped assembly in which DAN-family antagonists occlude both type I and type II receptor motifs, distinct from Noggin's mode.\",\n      \"evidence\": \"X-ray crystallography at 2.9 Å with binding validation\",\n      \"pmids\": [\"27524626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Grem2-GDF5 aggregates in vivo unknown\", \"Selectivity of DAN family for GDF5 vs other BMPs not fully mapped\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mapped a >100 kb array of modular enhancers controlling Gdf5 expression in distinct joint subsets, explaining its spatially precise skeletal deployment.\",\n      \"evidence\": \"Transgenic enhancer reporters and functional rescue in Gdf5 mutant mice\",\n      \"pmids\": [\"27902701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific transcription factors at each enhancer only predicted\", \"Enhancer-promoter looping architecture not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified the GROW1 long-bone enhancer regulating Gdf5 at growing bone ends, with a positively selected human variant that lowers enhancer activity, linking GDF5 regulation to human skeletal evolution.\",\n      \"evidence\": \"Transgenic enhancer assays, in vivo GROW1 deletion, human variant reporters, population genetics\",\n      \"pmids\": [\"28671685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular consequence of the variant on bone length in humans not directly measured\", \"Trans-factors at GROW1 unidentified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a BMP14/GDF5-Sirt1-JNK/Smad1-PPARγ pathway driving tenogenic differentiation of mesenchymal stem cells.\",\n      \"evidence\": \"BMSC treatment, Sirt1 gain/loss, JNK/Smad inhibitors, acetylation assays\",\n      \"pmids\": [\"30116367\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo tendon repair relevance not established\", \"Receptor route to JNK/Smad1 activation not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed GDF5 downstream of an embryonic CaVβ1 isoform in denervated muscle, linking GDF5 induction to muscle mass maintenance during aging.\",\n      \"evidence\": \"CaVβ1E gain/loss-of-function mouse models, denervation, GDF5 expression measurement\",\n      \"pmids\": [\"31694926\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GDF5 signaling effectors in muscle not defined\", \"Causal sufficiency of GDF5 for muscle phenotype not isolated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed Gdf5 is upregulated in articular cartilage after osteoarthritis and injury through a downstream regulatory sequence and is repressed by YAP, tying GDF5 to injury-responsive repair signaling.\",\n      \"evidence\": \"Gdf5-LacZ reporter mice, DMM and acute injury models, YAP overexpression, human OA microarray\",\n      \"pmids\": [\"31932746\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling YAP to the regulatory sequence unknown\", \"Functional benefit of injury-induced GDF5 not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the GDF5-specific co-receptor inferred from context-dependent BMP2 antagonism, and the unifying structural rules linking receptor-binding and Noggin-binding interfaces across GDF5 disease mutations, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No co-receptor molecularly identified\", \"No single structural framework reconciles overlapping receptor/antagonist interfaces\", \"Causal in vivo link from cis-regulatory variants to osteoarthritis progression unproven\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 8, 9, 29, 30]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 6, 9, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 21, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 5, 23, 24, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 9, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 10, 28, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMPR1B\", \"BMPR1A\", \"BMPR2\", \"NOG\", \"GREM2\", \"ROR2\", \"XIAP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}